Next Article in Journal
Recent Advances in Antifreeze Peptide Preparation: A Review
Next Article in Special Issue
Cytotoxic and Antibacterial Activity of Koninginins Isolated from the Mangrove-Derived Endophytic Fungus Trichoderma sp.
Previous Article in Journal
A Computational Study of Heteroatom Analogues of Selenoxide and Selenone syn Eliminations
Previous Article in Special Issue
Essential Oil-Based Soap with Clove and Oregano: A Promising Antifungal and Antibacterial Alternative against Multidrug-Resistant Microorganisms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review

1
College of Food Science and Engineering, Henan University of Technology, Zhengzhou 450001, China
2
Biology Department, College of Science, UAE University, Al Ain P.O. Box 15551, United Arab Emirates
3
Department of Sustainable Crop Production, Università Cattolica del Sacro Cuore, Via Emilia Parmense 84, 29122 Piacenza, Italy
4
Department of Medical Laboratory Technology, Riphah International University, Faisalabad 44000, Pakistan
5
Department of Biological Sciences, Pakistan Institute of Engineering and Applied Sciences, Islamabad 45650, Pakistan
6
Department of Biotechnology, National Institute for Biotechnology and Genetic Engineering, Faisalabad 38000, Pakistan
7
Department of Biotechnology, Government College University, Faisalabad 38000, Pakistan
8
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, 800 Dongchuan Road Shanghai, Minhang District, Shanghai 200240, China
9
Zhongjing Research and Industrialization Institute of Chinese Medicine, Zhongguancun Scientific Park, Meixi, Nanyang 473006, China
10
Henan Biological Industry Group, 41, Nongye East Rd, Jinshui, Zhengzhou 450008, China
11
Peng Cheng National Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, Shenzhen 518055, China
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(20), 4914; https://doi.org/10.3390/molecules29204914
Submission received: 23 September 2024 / Revised: 14 October 2024 / Accepted: 14 October 2024 / Published: 17 October 2024
(This article belongs to the Special Issue Advances in Natural Products and Their Biological Activities)

Abstract

:
Nigella sativa (N. sativa; Ranunculaceae), commonly referred to as black cumin, is one of the most widely used medicinal plants worldwide, with its seeds having numerous applications in the pharmaceutical and food industries. With the emergence of antibiotic resistance in pathogens as an important health challenge, the need for alternative microbe-inhibitory agents is on the rise, whereby black cumin has gained considerable attention from researchers for its strong antimicrobial characteristics owing to its high content in a wide range of bioactive compounds, including thymoquinone, nigellimine, nigellidine, quercetin, and O-cymene. Particularly, thymoquinone increases the levels of antioxidant enzymes that counter oxidative stress in the liver. Additionally, the essential oil in N. sativa seeds effectively inhibits intestinal parasites and shows moderate activity against some bacteria, including Bacillus subtilis and Staphylococcus aureus. Thymoquinone exhibits minimum inhibitory concentrations (MICs) of 8–16 μg/mL against methicillin-resistant Staphylococcus aureus (MRSA) and exhibits MIC 0.25 µg/mL against drug-resistant mycobacteria. Similarly, quercetin shows a MIC of 2 mg/mL against oral pathogens, such as Streptococcus mutans and Lactobacillus acidophilus. Furthermore, endophytic fungi isolated from N. sativa have demonstrated antibacterial activity. Therefore, N. sativa is a valuable medicinal plant with potential for medicinal and food-related applications. In-depth exploration of the corresponding therapeutic potential and scope of industrial application warrants further research.

1. Introduction

The unselective and inappropriate use of antibiotics in human healthcare has led to the rapid emergence and propagation of antibiotic resistance in pathogenic bacteria, whereby these microbes acquire resistance to a wide range of common antibiotics, a phenomenon known as multidrug resistance (MDR) [1]. Antibiotic-resistant pathogens pose a great challenge in the global healthcare sector, as they increase morbidity, mortality, the economic burden associated with infectious disease incidence, and the need to find effective alternative treatments against them (Centers for Disease Control and Prevention, 2019) [2]. Indeed, the increasing number of MDR microbial strains identified in community-acquired infections has become the cause of increasing global alarm [3]. In this situation, the World Health Organization (WHO) prioritizes the development of alternative drugs, considering the alarming increase in the number of MDR species and their harmful effects on the health of people worldwide [4]. Therefore, scientists, clinicians, and researchers are working to test different agents as substitutes for antibiotics, such as bacteriophages, bacteriocins, nanoparticles, and seed and herbal extracts with antimicrobial properties [5]. Besides the usefulness of plant-based antimicrobial agents against infections, there is a potential chance of resistance development in pathogens against them, too, particularly in case of prolonged use. This possibility can be predicted by the extensive research reporting the emergence of antimicrobial resistance in pathogens owing to the prolonged or repeated use of conventional antibiotic drugs [6]. Several studies have reported the detrimental effects of antibiotic drugs on gut microbiota composition and gastrointestinal health, raising concerns that long-term use of phytochemical drugs for infectious diseases in clinical settings could lead to similar issues [7]. However, medicinal plants, such as N. sativa (commonly known as black seed or cumin), with their rich array of bioactive compounds, offer potential therapeutic benefits that could help mitigate such health problems. The species is predominantly found in Uzbekistan, Egypt, Southern Europe, Southwest Asia, North Africa, India, and Pakistan. In South Asia, it is called “Kalongi”, and its Arabic name is “Habib-ul-Saua”. It is very important in Greek medicine and Islamic culture, with a long history of conventional use, and is well known for its broad-spectrum pharmacological characteristics [8,9]. Cumin essential oil yields obtained in different countries are listed in Table 1. Most Nigella seeds contain over 30% oil, with some reaching up to 40% [10]. Yield variations arise from environmental factors, such as water stress, saline conditions, and cooler temperatures, reducing yields to 13–23% in places such as Italy [11], similar to regions such as Northwestern Morocco. Both genetic differences and environmental factors, such as altitude and temperature, significantly impact yields and bioactive compound levels, as seen in Indonesia, Kuwait, and India [12]. The method of extraction also affects yield, with solvent extraction being more efficient than cold pressing [13]. These variations are crucial in determining the medicinal and nutritional quality of the oil.
Natural compounds with in vitro therapeutic potential are abundant in N. sativa, and include organic antioxidants with antidiabetic, anti-inflammatory, anti-cancer, and wound-healing properties, as well as antibacterial and antifungal activities. N. sativa has long been used traditionally for treating bacterial infections, such as in Iran and Pakistan [25,26]. Empirical studies have now confirmed its antibacterial properties, with modern research showing thymoquinone’s efficacy against drug-resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and mycobacteria [27,28]. Historically, cumin has been used to treat various illnesses worldwide, especially in Eastern Europe, the Middle East, Western Asia, and Central Asia [29] (Figure 1). Its importance in the Islamic culture derives from it being considered a curative drug [30]. Cumin seeds’ physical and nutritional properties are well known [31]. Although the volatile oil from N. sativa seeds has neuroprotective and therapeutic effects against sciatic nerve injury, these effects have mainly been observed in terms of neuronal number and morphology [32]. Overall, cumin seed oil can be considered a potential food supplement to enhance memory, attention, and cognition [33].
Nigella sativa seeds are rich in alkaloids, proteins, saponins, and fixed and volatile essential oils. Particularly, thymoquinone (TQ), the main constituent of the essential oil, is responsible for a large portion of the biological activity of the seed extracts. The fixed oil contains mainly O-cymene [34]. Meanwhile, the lipid portion of black seed contains valuable fatty acids and sterols, such as linoleic and oleic acids, b-sitosterol, and stigma sterol. In turn, proteins and peptides isolated from N. sativa reportedly exhibit a variety of bioactive effects, such as antibacterial, anti-cancer, and anti-inflammatory [9]. All these compounds have shown moderate activity against Staphylococcus aureus but poor activity against Shigella species and Klebsiella pneumoniae [35]. Essential fatty acids, glycolipids, phospholipids, and bioactive phytosterols are abundant in the fixed oil [36]. Further, the antibacterial efficacy of the essential oil extracted from N. sativa seeds against clinical isolates of bacteria resistant to different antibiotics was investigated using the “disc agar diffusion technique” and saturated filter-paper discs on inoculated Muller Hinton agar plates. The results showed that Gram-positive bacteria were more susceptible than Gram-negative ones to the antibacterial action of the essential oil in a dose-dependent manner [37].
Cumin is one of the best-ranked, evidence-based herbal remedies and, by and large, TQ is the key component responsible for the medicinal properties reported [30], and with a long history of use in conventional medical systems, including Chinese, Greco-Arabic, Islamic, Unani, and Ayurvedic, N. sativa is an excellent source of TQ. In addition to the above-mentioned curative effects, TQ is a potential treatment for skin diseases because of its antimicrobial, anti-inflammatory, and antineoplastic properties [38].
Research has shown that the aqueous N. sativa extract does not exhibit any microbial activity against Pasteurella multocida, whereas the ethanolic extract shows some activity against this strain but none against S. aureus [39].
Additionally, with an oil content exceeding 35%, there is great interest in using cumin seeds as a “feedstock” for the production of biofuels. The transesterification reaction for this process can be initiated through alkali-, acid-, or enzyme-catalyzed methods. However, the efficacy of the primary catalysts may be significantly diminished when the feedstock contains substantial amounts of fatty acids, whose presence in cumin oil poses a challenge to the use of homogenous alkali catalysts, as they lead to saponification, thereby depleting the catalysts and increasing subsequent purification costs. Although enzymes can facilitate a straightforward purification process for biodiesel and glycerol, they may not be suitable for industrial-scale applications [40].
Additionally, it has been demonstrated that endophytic fungi isolated from N. sativa are a rich source of organic chemicals with biological activity, including bioactive metabolites derived from fermentation in PDA culture media. Thus, crude endophyte extracts have shown promising antibacterial activity against both Gram-positive and Gram-negative bacteria [41].
Lastly, high-quality antioxidant-rich N. sativa extracts can be produced via supercritical fluid extraction [42].
The objective of this review is to integrate the critical clinical aspects of N. sativa to facilitate the identification of more active ingredients and their significance to human health.

2. Bioactive Compounds Found in N. sativa

Naturally occurring compounds can alter living cells. In particular, N. sativa seeds contain carbohydrates, proteins, lipids, and vitamins, and specific combinations and interactions of these macromolecules contribute to their crucial role in improving the immune system and its functionality [43]. Recently, several bioactive substances from a range of black cumin seed variants have been extracted, identified, and recorded. These compounds are distinguished by their specific biological activities and impacts on human health, which determine their therapeutic roles in various medical conditions [44]. N. sativa mainly contains alpha-hedrein, carvacrol, nigellimine, N-oxide, nigellicine, p-cymene, carvacrol, 4-terpineol, t-anethole, sesquiterpene, α-pinene, thymol, TQ, and alkaloids, such as pyrazole alkaloids and uncommon indazole ring alkaloids that show remarkable biological activities [45,46,47] (Figure 2a). Furthermore, the distribution of bioactive compounds in N. sativa has been comprehensively examined, with an emphasis on composition diversity [46] (Figure 2b).
Studies have shown that black cumin seed oil primarily consists of fatty acids, with linoleic and palmitic acids accounting for 64.6% and 20.4% of their composition, respectively. Further, the seed oil contains 0.4–2.5% essential oil [48,49]. The seeds contain a remarkable number of fibers, with soluble fibers comprising from 20.5 to 27.1 g 100 g−1, while the insoluble portion reaches up to 6.5–8.9 g 100 g−1. Moreover, 18–42% of black cumin seed oil is composed of sterols, predominantly β-sitosterol, campesterol, stigmasterol, and 5-avenasterol [17]. In turn, α-, β-, and γ-tocopherol add up to 9.15–27.92 mg 100 g−1 of the seed oil [50,51].
Black cumin seeds are a good source of saponins, including alpha-hederin, a water-soluble pentacyclic triterpene with potential anti-cancer effects. Additionally, studies have found trace quantities of some other compounds, such as carvone, limonene, citronellol, flavonoids, coumarins, and tannins [52,53,54]. The exact composition of the various elements found in cumin seed oil is determined by different factors, e.g., the specific plant source, the conditions under which the seed was stored, and the method of extraction used, such as supercritical CO2 extraction (SC-CO2; 1.06–4.07 mg g−1) or Soxhlet extraction (2940.43 mg kg−1 and 8.8 mg g−1) [55,56]. Furthermore, phytochemical analysis has revealed the presence of over 100 phytonutrients in N. sativa seeds, although the chemical characteristics and biological activities of a significant number of these nutrients remain unidentified and unverified. Below, we summarize our current knowledge on the specific biological functions and health benefits of various types of chemical compounds found in N. sativa seeds.

2.1. Terpenes and Terpenoids

2.1.1. Thymoquinone

Generally known as TQ, 5-isopropyl-2-methyl-1,4-benzoquinone is the most important bioactive compound isolated from N. sativa seed oil. This compound has various therapeutic effects on the human body [57], including, in addition to those mentioned above, effects on metabolic disorders, such as obesity, diabetes mellitus, dyslipidemia, high blood pressure, and metabolic pathway disturbances, which lead to cardiovascular disease (CVD) [58]. Indeed, several studies have focused on the evaluation of the pharmaceutical significance of TQ and its derivatives [59,60]. Thus, many studies on humans and animals have verified the potential role of TQ in balancing the serum lipid profile [61]. Moreover, TQ can reduce the activity of HMG-CoA reductase in the liver, enhance erylesterase, and regulate genes involved in cholesterol metabolism, ultimately preventing dyslipidemia and other metabolic conditions [62]. Furthermore, various studies have reported that the role of TQ in cardiovascular disease treatment might be closely associated with its ability to reduce the activity of β-hydroxy β-methylglutaryl HMG-CoA reductase and, subsequently, lower total cholesterol levels. Experiments in rats have demonstrated that TQ effectively alleviates hypertension [63].

2.1.2. P-Cymene

Chemically a monoterpene, p-cymene is a prominent component found in essential oils derived from diverse plant species [64]. Some studies revealed that p-cymene exhibited antioxidant properties in vivo, while holding potential as a neuroprotective agent within the brain. This compound could offer a novel approach to crafting treatments for various diseases wherein oxidative stress significantly contributes to the observed pathophysiology [65]. P-cymene has an extensive range of pharmacological effects, including antibacterial, antioxidant, anti-inflammatory, antiparasitic, antidiabetic, antiviral, and antitumor activities. Particularly, p-cymene has potential as an anti-inflammatory agent by effectively modulating cytokine production, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), and interleukin-10 (IL-10), through inhibition of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Additionally, studies have indicated its analgesic/antinociceptive and immunomodulatory properties, along with the hypotensive and bradycardic effects observed in urethane-anesthetized rats [66]. Further, p-cymene serves as a significant industrial intermediate and is used in the manufacture of fungicides, pesticides, perfumes, and fragrances; lastly, it is also used in the production of certain precursors of common antioxidants, such as p-cresol [67].

2.1.3. Carvacrol

Known as carvacrol, ‘5-isopropyl-2-methylphenol’ is an important monoterpene obtained from black cumin seeds with a range of biological activities, including antibacterial and antifungal properties [68]. Carvacrol inhibits the proliferation of both Gram-positive and Gram-negative bacteria, successfully deterring biofilm formation. It has emerged as a potential substitute for conventional antimicrobial agents against MDR bacteria. This bioactive compound is prevalent in various plants, such as oregano, thyme, sweet basil, black cumin, and food savory, and is used for medicinal purposes in many regions. In addition to its pharmacological applications, carvacrol is also used as a feed supplement to enhance the performance of livestock and improve the quality of meat and eggs [69]. Researchers continue to explore its bioactive properties and how to take advantage of such properties in the health and livestock industries. Despite their promising medical prospects, further investigations into the toxicity and potential side effects of these compounds are needed [70].
The supplementation of poultry feed with carvacrol has demonstrated efficacy in enhancing the quality of poultry meat by suppressing tissue lipid oxidation, a significant deterioration process that affects both the sensory and nutritional attributes of food. This feed supplementation approach offers a straightforward and convenient method for introducing lipid-soluble antioxidants into phospholipid membrane tissues that can effectively prevent oxidative reactions at localized sites. Additionally, increasing concerns regarding the safety of synthetic antioxidants, such as butylated hydroxytoluene or butylated hydroxyanisole, have spurred further investigation of plant constituents, such as carvacrol [71].

2.1.4. Camphene

Camphene is a monoterpene extracted from N. sativa seeds. A study showed that this compound altered cholesterol and triglyceride levels. The experiment involved normal rats and rats exposed to detergents that made them prone to high cholesterol levels. Camphene administration significantly reduced LDL cholesterol and triglyceride levels in rats with increased cholesterol levels. The mode of action of camphene differs from that of mevinolin and other cholesterol-lowering drugs. It lowered blood cholesterol levels without effecting HMG Co-A reductase. The same study demonstrated the anti-cancer activity of camphene, which was a result of apoptosis induction in melanoma cells via an intrinsic pathway, along with the release of calcium ions, HMG B1, and calreticulin, which cause stress in the endoplasmic reticulum. Furthermore, the importance of this compound has increased because of its antitumor activity in aggressively growing melanoma cells [72].

2.1.5. Thymol

Thymol, another compound found in N. sativa, provides diverse health benefits. Research indicates that thymol, along with other constituents, such as thymoquinone, exhibits antimicrobial, anti-inflammatory, and COX-1 and COX-2 inhibitory properties, suggesting considerable potential as a nonsteroidal anti-inflammatory agent [73,74]. Studies have also focused on the potential of N. sativa-derived thymol as an anti-proliferative and anti-cancer agent, highlighting its ability to suppress cell proliferation and combat cancer [75]. N. sativa is associated with a broad spectrum of therapeutic effects, including antioxidant, anti-inflammatory, cough-suppressing, gastroprotective, anxiolytic, ulcer-preventing, asthma-reducing, cancer-fighting, immune-modulating, and liver-protective effects [76].

2.1.6. Terpineol

Alpha-terpineol (α-T), a monoterpenoid present in numerous essential oils, has extensive applications in fragrances, cosmetics, culinary and domestic products, and antiseptic agents; moreover, it shows significant bioactivity [77], including antihypertensive, antioxidant, analgesic, gastroprotective, anticonvulsant, and sedative properties. Furthermore, α-T enhances transdermal penetration and has potential as a natural insecticidal agent. These characteristics render it a promising candidate for pharmaceutical and agrochemical applications [78]. Finally, terpineol, particularly 4-terpineol found in the essential oil of black cumin seeds, demonstrated significant radical-scavenging properties and effective antioxidant activity in various assays, including lipid peroxidation and deoxyribose degradation [79].

2.2. Alkaloids

2.2.1. Nigellidine

Nigellidine is an alkaloid that belongs to a group of naturally occurring compounds containing basic nitrogen atoms [80]. It is a bioactive compound extracted from N. sativa seeds using column and thin-layer chromatography techniques [55]. The biological activity of nigellidine is attributed to its chemical structure, which contains an indazole ring system [81]. Previous studies have suggested that nigellidine exerts various pharmacological effects. One of these studies indicated that nigellidine may substantially inhibit TNF-induced inflammatory signaling and Fas-induced apoptotic death signaling, demonstrating greater efficacy than the positive control drug, oseltamivir [82]. Nigellidine from N. sativa showed strong potential in targeting COVID-19 proteins and inhibiting IL1R–IL6R, demonstrating antioxidative, hepato-reno-protective, immunomodulatory, and anti-inflammatory activities [83].
Several chemical variants of nigellidine have been isolated from black cumin as well. Nigellidine-4-O-sulfite was the first sulfated alkaloid of this type. Nigellimine and nigellimine N-oxides are isoquinoline alkaloids. Several dolabellane-type diterpene alkaloids, nigellamines A1–A5, have been isolated from N. sativa. Natural indazole-type alkaloids were obtained only from N. sativa, indicating that they might serve as potential taxonomic markers [84].

2.2.2. Nigellamines

Black cumin seeds are rich in nigellamines, particularly nigellamines A1 and A5, which are diterpene alkaloids found in N. sativa seeds that are known for their significant biological activities. An experimental study demonstrated that nigellamines A3, A4, A5, and nigellamine C, obtained from the essential oil of black cumin seeds, are capable of lowering triglyceride levels in mouse hepatocytes; specifically, the effect of nigellamine A5 is comparable to clofibrate [85]. Moreover, the synthesis of other nigellamine alkaloids is now possible, as scientists have synthesized nigellamine A2 and confirmed its stereochemical confirmation [86]. Other Nigella species also contain a wide range of alkaloids, such as a novel compound called nigeglanine, which comprises an indazole nucleus isolated from N. glandulifera seeds and has pharmacological properties. A previous study showed that nigeglanine had a positive impact on intestinal health by protecting the colon from loss of length and preventing epithelial cell damage [87]. Additionally, several studies have demonstrated the therapeutic strength of nigellamines, mainly A1 and A5, in regulating lipid metabolism [88].

2.3. Polyphenols

2.3.1. Vanillic Acid

Roots and shoots of N. sativa plants are good sources of polyphenols, such as vanillic acid (VA), obtained in the methanolic extract [88], which shows neuroprotective activity and is effective in the management of vascular dementia and cerebrovascular failure. Its pharmacological significance is due to its role in mitigating inflammation and the symptoms of various neurological diseases [89]. Owing to its anti-inflammatory characteristics, this polyphenol plays a therapeutic role in asthma and other respiratory disturbances, as it reduces pro-inflammatory cytokines, subsequently relieving inflammation in the lungs and air passageways [90]. Numerous studies have reported that VA can be used as a constituent of functional foods and as a dietary supplement for the prevention of neural disorders [91].

2.3.2. Caffeic Acid

Also known as caffeic acid (CA), 3,4-dihydroxycinnamic acid is a polyphenolic compound with strong antioxidant characteristics found in black cumin seeds. Besides being a potent antioxidant, CA possess anti-inflammatory, immunoregulatory, and anti-cancer effects [92]. The chemical conformation of CA, characterized by free phenolic hydroxyls and a double bond in the carbonic chain, enables it to exert antioxidant and pro-oxidant activities in metastatic cells, making it a potential anti-cancer agent [93]. A previous study demonstrated that CA also stimulates apoptosis in multiple myeloma cells via the caspase-dependent pathway [92].

2.3.3. Flavone

Flavone is another phenolic compound obtained in the methanolic extracts obtained from roots and shoots of the black cumin plant [88]. A recent study investigated the impact of a crude flavonoid extract derived from N. sativa and reported that it inhibited the proliferation of MCF-7 human breast cancer cells and is, therefore, a potential therapeutic agent for the treatment of breast cancer [94]. Another study that focused on N. sativa as a reducing agent found that an aqueous extract of black cumin seeds can be used as a coating for gold nanoparticles, as well as a reducing agent. Further experiments using the alpha-amylase method demonstrated considerable antidiabetic effects of these nanoparticles [95].

2.3.4. Catechins

Nigella roots and shoots are a good source of catechins, which have significant anti-inflammatory and antioxidant properties, which make them important pharmacological agents [96]. Catechin can increase the production of adipocytes and prevent TNF-α-induced inflammatory responses [96].

2.4. Fatty Acids

Nigella sativa seeds of are rich in a wide range of saturated and unsaturated fatty acids, including palmitic, lenoleic, stearic, oleic, butyric, lauric, and myristic acids, which exhibit several features that can be useful in therapeutics [97].

2.4.1. Palmitic Acid

Palmitic acid is a saturated fatty acid that accounts for 12.5% of the black cumin seed oil [98]. It is involved in numerous metabolic mechanisms, including modulation of CD-36 cells and AMP-activated protein kinase [99]. A study on the lipid content of N. sativa and its effects on the immune system reported that palmitic acid plays a direct role in increasing the secretion of interleukin 6 (IL-6) and 3T3-L1 adipocytes [100]. A previous study reported that intracerebroventricular (icv) injections of palmitic acid in experimental mice led to reduced leptin sensitivity and leptin-induced changes in liver gluconeogenesis and lipogenesis. These findings demonstrate the role of palmitic acid in the management of homeostatic disorders associated with the liver and obesity [101].

2.4.2. Linoleic Acid

Linoleic acid is another important fatty acid found at the highest concentration (58.9%) in the essential oil of N. sativa and contributes significantly to its nutritional value [98,102]. Linoleic acid mitigates and prevents obesity-induced health issues [103]. Moreover, the cytotoxic and anti-cancer properties of N. sativa seeds have also been attributed to linoleic acid, as, in particular, it stimulates apoptosis in ovarian carcinoma and can, therefore, be utilized as an anti-cancer therapeutic agent [104].

2.4.3. Oleic Acid

Oleic acid is a monosaturated fatty acid that accounts for 28% of the oil in black cumin seeds [98]. Oleic acid has several health benefits, including improvement of insulin sensitivity, reduction of inflammation, and prevention of insulin resistance [105]. Oleic acid enhances carnitine palmitoyltransferase 1 (CPT-1) levels and forces fatty acids into the mitochondria, thereby reducing ceramide in cells exposed to high palmitic acid [106]. Oleic acid was also found to have a protective effect on hepatocytes by inducing autophagy and triacylglycerol production, thereby preventing apoptosis of these cells [107]. It also plays a role in protecting the human body from atherosclerosis and insulin resistance associated with the cardiovascular system [105].

2.5. Phytosterols

The black cumin seed oil has a comprehensive chemical profile that also includes phytosterols, such as β-sitosterol, campesterol, stigmasterol, and 5-avenasterol, exhibiting numerous health advantages. These plant-based sterols assist in lowering the cholesterol levels in the body [108].

2.5.1. Campesterol

Campesterol, an important bioactive compound present in N. sativa seeds, has also been studied for its health benefits. Research has shown that campesterol is a good therapeutic option for arthritis, as it reduces paw edema in rats and lowers the levels of inflammation-inducing cytokines, such as IL-1, TNF-α, NFκ-B, IL-6, and COX-II. Furthermore, campesterol stimulates the production of anti-inflammatory interleukin-4 (IL-4) and induces homeostasis of blood chemistry, subsequently alleviating the severity of symptoms in rheumatoid arthritis patients [109].

2.5.2. Cholesterol

Plant-based lipids and cholesterol are good for health because they are mostly comprised of high-density lipoproteins (HDL), while animal sources increase the level of low-density lipoproteins (LDL), generally regarded as “bad cholesterol”. Black cumin seed oil intake reduces the risk of cardiovascular disorders by balancing serum cholesterol [110]. In addition, detailed studies have reported anti-hypercholesterolemic effects of N. sativa. Due to the presence of various phytosterols, the seed oil of N. sativa can boost arylesterase function, an indicator of cardiovascular health, while reducing serum HMG-CoA reductase levels, thereby helping in regulating the lipid profile [111,112].

2.5.3. Stigmasterol

Stigmasterol is an unsaturated plant sterol, classified as a tetracyclic triterpene. Among phytosterols, stigmasterol is the most frequently extracted sterol from the oils of numerous plants, herbs, and vegetables, and has a wide range of therapeutic and pharmacological applications [113]. Stigmasterol is a food additive recognized as E499 in the European Union and is used in the food industry to increase phytosterol content and balance LDL cholesterol in various products [114]. It is a C24 alkylated cholesterol that functions as a component of the cell membrane and contributes to its strength and stability [115]. Stigmasterol increases the transport of glucose transporter type 4 (GLUT4), reduces fasting blood glucose levels, and treats insulin resistance; therefore, it is a potential antidiabetic agent [116]. This phytosterol has also been found to be therapeutic against skin, ovary, breast, prostate, and gastrointestinal tract carcinomas, contributing to the anti-cancer properties of N. sativa [117]. Moreover, studies have reported the role of stigmasterol as a strong antioxidant, anti-inflammatory, antimicrobial, immunoregulatory, and neuroprotective compound [118,119,120,121].
Several strains of viruses, fungi, and bacteria react differently to multiple bioactive substances, exhibiting distinct activities and modes of action, based on their different functions (Table 2).

3. In Silico Toxicity and Drug-Likeness Evaluation

To determine the potential of N. sativa compounds as therapeutic agents, a comprehensive overview of their toxicity profiles, cLogP, solubility, topological polar surface area (TPSA), drug-likeness, and drug score was evaluated using the Osiris Property Explorer (https://www.organic-chemistry.org/prog/peo/ accessed on 14 May 2024). Toxicity evaluation helps to understand the potential adverse effects that may arise from the consumption or application of these compounds. Their mutagenic, tumorigenic, and irritant properties were evaluated to gain valuable insights into their potential therapeutic value. For example, nigelidine, carvacrol, longifolene, p-cymene, and nigellimine have no mutagenic, tumorigenic, and irritating effects, indicating their potential for therapeutic use. Conversely, compounds such as lauric acid, camphor, carvone, benzaldehyde, and coumarin do have mutagenic and tumorigenic properties, whereby their therapeutic use advises caution (Table 3).
However, compounds such as nigellidine and epicatechin show favorable drug-likeness and high drug scores, suggesting their suitability for drug development. Conversely, compounds such as pentyl hexadec-12-enoate and lauric acid show poor drug-likeness and low drug scores, indicating their limited potential as viable drug candidates (Table 4). Based on this detailed toxicity assessment, the safety profiles and pharmacokinetic properties of the bioactive compounds present in N. sativa were evaluated to ensure their efficacy and safety in clinical trials. These properties provide researchers and clinicians with a better understanding of the therapeutic potential of N. sativa that will facilitate the identification and development of safe and effective antimicrobial agents without adverse effects.

4. Antioxidant and Immunomodulatory Properties of N. sativa

Antioxidants are molecules that inhibit the action of free radicals in the body and are highly damaging to health. Chemical analysis of the essential oil and various extracts of N. sativa have revealed their antioxidant properties [139]. By enhancing the activity of antioxidant enzymes, such as glutathione peroxidase, glutathione reductase, glutathione S-transferase, and catalase, TQ aids in neutralizing free radicals and reactive oxygen species (ROS) [139,140]. Furthermore, cyclooxygenase and 5-lipoxygenase in the arachidonic acid metabolic pathway are blocked by various bioactive chemicals found in Nigella seed oil. Thin-layer chromatography was used to separate TQ, carvacrol, t-anethole, and 4-terpineol from the black cumin seed oil. Additionally, their synergistic antioxidant properties were confirmed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) test [141]. Clinical investigations have reported that Nigella seed oil, specifically TQ, reduces the arthritis activity scale score (disease activity score, DAS 28) and bone resorption in patients with rheumatoid arthritis. Similarly, another experimental study reported the excellent ability of N. sativa to affect inflammatory processes and reduce oxidative stress. Its components inhibit the activity of NF-κB by inducing IL-6, TNF-α, and other cytokines, consequently reducing inflammation [141]. Additionally, TQ has an inhibitory effect on eicosanoids and other pro-inflammatory factors of the immune system, including NF-κB/STAT3. NF-κB has been found to primarily induce inflammation, specifically in rheumatoid arthritis patients [142]. Further, researchers have studied the correlation between various extracts derived from N. sativa seeds and the in vitro response of peripheral blood mononuclear cells (PBMC) to different mitosis-inducing antigens (mitogens) [50]. Another in vitro study using splenic mixed lymphocyte culture and ethyl acetate column chromatography techniques proposed a considerable suppressive role of black cumin seed extracts in the humoral immune response [141]. In addition, N. sativa contains compounds capable of activating CD4+ T-helper cells that further differentiate into Th1 or Th2 cells, thereby affecting cytokine production and specific outcomes of adaptive immunity in various disorders. Reliable in vivo studies have also reported the immunoregulatory role of N. sativa in the T-helper-to-T-suppressor cell ratio and the cytotoxic effects of natural killer cells [143,144] (Figure 3).

5. Antimicrobial Activities of N. sativa

The quest for adequate substitutes for existing antibiotic drugs with different modes of action against pathogenic microbes has led scientists to identify medicinal plants with potential antimicrobial capabilities [145]. Thus, numerous studies have shown that various plant phytochemicals, including anthraquinones, phenolics, flavonoids, alkaloids, terpenoids, saponins, and tannins, are beneficial against microbial infections. By preventing growth, altering the permeability of cellular membranes, interfering with metabolism, and modifying gene expression, these substances can kill bacteria, viruses, or fungal cells [146] (Figure 4). Studies investigating the antimicrobial strength of Nigella sativa have employed rigorous extraction techniques, clinical procedures, and statistical analyses to demonstrate its effectiveness against various pathogens. Shafodino’s study on the phytochemical profile and antimicrobial properties of black cumin seeds used the sequential maceration method for extraction, disk diffusion for antimicrobial testing, and SPSS version 24, with a significance threshold of p < 0.05 for statistical analysis [147]. Furthermore, the statistics of the antibacterial strength of N. sativa against different classes of bacteria showed that it is more effective against Gram-positive strains than Gram-negative ones (p < 0.0001) [148]. Among other species, E. coli, P. aeruginosa, and S. aureus were found to be more susceptible to the essential oil of N. sativa [147]. A subsequent study clearly highlighted the tannin content and antibacterial ability of two different varieties of N. sativa by using one-way ANOVA (Tukey’s test) [149].

5.1. Antibacterial Abilities

Nigella sativa seed extracts were studied for their antibacterial properties against various pathogenic bacterial species by adding varying concentrations of TQ to the bacterial culture. Subsequent measurement of minimum inhibitory concentrations (MIC) showed the antimicrobial potential of these extracts against Pseudomonas aeruginosa (ATCC 14886), Bacillus subtilis (ATCC 6633), Escherichia coli (ATCC 25922), and Staphylococcus aureus (ATCC 9144) [150]. Moreover, experiments have shown an effective inhibitory response of Nigella seed extracts against some strains of Enterococcus faecalis, Aacinetobacterjunii, E. coli, S. aureus, Enterobacter cloacae, Serratia marcescens, and Proteus mirabilis. Particularly, E. faecalis, Acinetobacter junii, E. coli, P. mirabilis, and S. marcescens were susceptible to the ethanolic extract, with a minimum inhibitory concentration of 5 mg/mL. Meanwhile, the methanolic extract had a 25 mg/mL MIC against S. aureus, whereas the isolates were resistant to the ethanolic extract. In the same experiment, MIC values of other extracts, such as chloroform, n-hexane, diethyl ether, butanolic, and acetonic extracts, against the above-mentioned pathogenic species demonstrated the effectiveness of N. sativa as an antimicrobial agent [151]. Another study focused the role of TQ in inhibiting biofilm formation using the crystal violet assay, colony-forming unit method, and scanning electron microscopy (SEM). TQ effectively degraded biofilms of S. aureus, P. aeruginosa, E. coli, and B. subtilis by producing ROS [150].
In light of the decreased effectiveness of existing antibiotics against bacteria, some studies have evaluated their use in combination with N. sativa to boost their antimicrobial activity and deal with antibiotic resistance. An experimental study reported the decrease in the MIC of several antibiotics when combined with oil extracts of N. sativa against resistant strains [152]. The collective use of β-lactam antibiotics and antibacterial compounds extracted from N. sativa was found effective against MRSA, causing greater bacterial inhibition and disruption of the bacterial cell wall [153]. Moreover, silver nanoparticles (AgNPs) obtained from N. sativa seeds can be integrated with streptomycin and ciprofloxacin to improve their antibacterial efficacy against MDR strains [154].

Activity of N. sativa Against Mycobacterium tuberculosis

Tuberculosis (TB) is a fatal respiratory infection caused by Mycobacterium tuberculosis (MTB), which affects over a million people every year globally [155]. According to the WHO, approximately three million people die of TB, whereas eight million silently develop various chronic infections, including TB. The administration of a combination of antibiotics for an extended period is a common practice for treating TB. However, these drugs have many side effects in patients, and their excessive use reduces bacterial susceptibility. The increasing number of MDR mycobacteria is a central issue for disease management purposes. Therefore, there is a need to replace antibiotics that have been in use for the past 40 years [156]. In view of this challenge, new therapeutic options are required to treat TB rapidly and effectively [157]. Several studies have been conducted in recent years to investigate the anti-mycobacterial potential of various extracts of N. sativa. Detailed research has shown that the MTB H37Rv strain is susceptible to the methanolic extract of N. sativa. In turn, the aqueous extract inhibited all three MDR strains of MTB; however, they were resistant to chloroform extracts [73]. Moreover, it has been shown to exhibit inhibitory action against TB at a concentration of 20 mg/mL [158]. Considering the extensive range of antimicrobial properties shown by N. sativa and the emerging demand for new remedies to combat mycobacterial infections, a clinical investigation demonstrated the in vitro activity of TQ against MTB isolated from the sputum specimens of patients with TB. Effective inhibition of MTB at a relatively low concentration of TQ, with a MIC of 20 μg/mL, was confirmed using the manual mycobacterial growth indicator tube method [158].
Bioactive substances derived from many plant sources, including 1,8-cineole, α-verbenol, citral b, TQ, piperitone, alantolactone, octyl acetate, and α-pinene, are under study for the development of novel medications against TB. These compounds are highly capable of disrupting the permeability of mycobacterial membranes [159]. Particularly, TQ derived from black cumin seeds has been reported to influence the mycobacteria-induced production of nitric oxide (NO) and inflammatory reactions in TB-infected type II human alveolar and myeloid cell lines, subsequently alleviating symptoms in patients with TB [160] (Figure 5). Indeed, TQ is efficient in immune regulation and exerts bacteriostatic action against intracellular pathogens. Importantly, this magic compound attacks drug-sensitive and drug-resistant strains of mycobacteria, with a lowest MIC of 0.25 µg/mL [161]. In addition to its antimicrobial activities, reports have found that TQ prevents possible hepatic dysfunction during anti-TB drug treatment, ensuring smooth and liver-friendly therapy [162].

5.2. Antiviral Activity

Bioactive components found in black cumin seeds also possess strong antiviral potential. These properties were studied extensively during the COVID-19 pandemic. Examination of the impact of Nigella seed oil on individuals with mild COVID-19 symptoms revealed that when patients were administered this oil at a dose of 500 mg/kg, there was a notorious attenuation of the symptoms of COVID-19. The group administered Nigella seed oil showed symptom alleviation for an average of approximately 10.7 days, compared to the 12.4-day average of the control group [163]. Several computational (in silico) studies have been conducted to better understand the antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An in silico analysis proposed that TQ can inhibit the activity of SARS-CoV-2 protease [164]. TQ is also involved in inducing viral oxidation, thereby protecting cells by modulating endosomes [165]. Additionally, molecular docking studies have found a possible anti-covalent role for TQ, which hinders viral protein interactions by preventing angiotensin-converting enzyme 2 (ACE2) [162]. Researchers have examined various natural compounds using computer simulation studies to detect their effects on the enzyme transmembrane serine protease 2 (TMPRSS2) [166]. They found that carvacrol (a bioactive compound in N. sativa) theoretically performed better at inhibiting TMPRSS2 than the control Comstat [166]. In contrast, thymol showed low inhibitory activity. Another computational study suggested that nigellone, also known as dithymoquinone, might block all essential targets of the coronavirus [167]. In addition, two compounds found in the seeds, nigellidine and kaempferol, are strongly associated with COVID-19 C19MP proteases [168]. However, the effectiveness of in silico approaches has limitations, including the need for high-performance systems to screen large compound libraries, reliance on structural data, and the requirement for validation through experimental and clinical studies, which may not be available for emerging targets [169,170]. Further randomized clinical trials are necessary to confirm the therapeutic potential of N. sativa in COVID-19 treatment.
Biologically active substances, particularly TQ, can be used as potential therapeutic agents against several viral infections, including influenza, dengue, Ebola, and hepatitis. The effects of N. sativa seeds on the pathophysiology and immunological response to H9N2 avian influenza virus (AIV) were investigated in Turkey [171]. The seeds of N. sativa boosted the production of T-helper and cytotoxic T cells, enhanced the expression of interferons, and reduced inflammatory mediators, consequently helping combat influenza viruses and other viral diseases [172].
Further, N. sativa compounds have been shown to be beneficial against dengue fever, a mosquito-borne global health risk. The extraction of secondary metabolites with antiviral characteristics from medicinal plants is a novel strategy owing to their distinctive structural and biochemical characteristics [173,174]. Lastly, TQ has been studied as an immune booster, as it significantly enhances antibody production and defends the body against various bacterial and viral infections [173].

5.3. Antifungal Activity of N. sativa

In addition to other antimicrobial properties, black cumin, a versatile healer, has a remarkable ability to fight fungal infections [175]. Researchers have conducted numerous studies to assess the antifungal activity of N. sativa against various fungal pathogens. The chemical composition of N. sativa includes a diverse range of bioactive compounds, each contributing to its unique biological properties. These compounds confer antifungal, cytotoxic, and other therapeutic effects, particularly TQ, which possesses substantial antifungal efficacy against pathogenic strains, such as M. gypseum. Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, T. mentagrophytes, M. canis, M. gypseum, P. digitatum, and C. gloeosporioides [139,176,177,178]. Moreover, nigellothionins extracted from black cumin seeds exhibit robust antifungal and cytotoxic properties [179]. N. sativa seed extract also has fungicidal activity against Aspergillus flavus and Aspergillus parasiticus [180].
Recent studies have confirmed the efficacy of black cumin against dermatophytes, such as Candida spp., Aspergillus, and Alternaria. The antifungal activity of methanolic extracts is superior to that of conventional treatments, such as clotrimazole. The concentration-dependent effects of black cumin ethanolic extracts suggest tailored therapeutic applications. The rich chemical composition of black cumin, which includes TQ, paves the way for novel antifungal interventions [181]. A previous study demonstrated the inhibitory effects of N. sativa seed oil on Fusarium solani. The hexane and ethanol fractions exhibited the greatest inhibitory effects (24–28 mm), surpassing those of the chloroform and methanol fractions (30–37 mm). Particularly, ethanolic extracts potently inhibit various fungi. The defense peptides (Ns-D1 and Ns-D2) from N. sativa seeds showed potent antifungal activity. This study highlighted the correlation between antimicrobial effects and components, such as thymohydroquinone, TQ, p-cymene, and longifolene, as well as the antimicrobial properties of unsaturated fatty acids and phenolics in black seed oil [182]. In 2013, Akansha et al. determined that the essential oils of clove buds and black cumin seeds, along with several other important components, exhibited antifungal properties against P. digitatum and C. gloeosporioides. The Poison food technique and MIC determination revealed significant growth inhibition of the pathogenic fungal strains. The synergistic effects of the combined essential oils and compounds were evaluated using fractional inhibitory concentrations (FIC), following CLSI guidelines [178]. Antifungal susceptibility testing (AFST) was conducted on 40 C. glabrata isolates using CLSI standards (https://clsi.org/standards/, accessed on 15 May 2024). The data revealed that 72.5% of these isolates were resistant to fluconazole (FLZ), 12.5% to itraconazole (ITZ), and only 5% to amphotericin B (AMB), while TQ had an MIC50 of 50 µg/mL. Biofilm formation in C. glabrata was reduced two-fold when exposed to the MIC50 of TQ, compared to that recorded for the control group, as assessed by an MTT assay [183].

5.4. Antiparasitic Features

The distinct chemical composition and structural characteristics of N. sativa seed oil bioactive components account for the wide range of antibacterial properties observed upon its application. The immunomodulatory, antioxidant, and cytotoxic effects of N. sativa have been demonstrated for the management of parasitic disorders and other infectious diseases.
Comprehensive research has demonstrated the antimalarial activity of ethanolic, aqueous, and chloroform extracts upon intraperitoneal administration in varying quantities. The initial assessment of N. sativa seed extracts revealed that all three extracts exhibited inhibitory effects against P. berghei infection in mice. Interestingly, higher doses did not necessarily result in greater suppression, except for the aqueous extracts used at 400 µL/kg, which showed significant suppression. The inhibitory effect of N. sativa oil and its components is due to its antioxidant properties, which prevent NO production in macrophages, a potent intracellular mechanism for killing parasites. This process also leads to the upregulation of secondary immune mechanisms, which the parasite cannot effectively counteract, ultimately weakening its defense and contributing to its clearance by the host’s immune system [184]. N. sativa seeds can render parasites susceptible to host damage, particularly schistosomiasis. Furthermore, N. sativa significantly protected cells against chromosomal aberrations induced by Schistosoma mansoni infection. In addition, it may protect against schistosomiasis by modulating the immune response and reducing inflammation [139].
Protozoan parasite-induced diseases cause considerable morbidity and affect the well-being of more than 500 million people worldwide. The pursuit of novel anti-protozoan medicines has escalated, particularly that of botanical remedies. TQ has demonstrated remarkable effectiveness against Entamoeba histolytica and Giardia lamblia, surpassing the potency of the commonly used drug metronidazole [185].
A previous study examined the effectiveness of N. sativa oil (NSO), applied either by itself or in conjunction with pyrimethamine (PYR), for the treatment of Toxoplasma gondii-caused toxoplasmosis. This research was conducted in a cohort of 100 albino mice, and the therapeutic interventions were compared with the prior amalgamation of clindamycin (CLN) and PYR. The study employed the virulent RH Toxoplasma strain to assess survival rates, liver and spleen impression smears, and histopathological and ultrastructural analyses. The evaluation also included measuring the levels of interferon-γ, total antioxidant capacity (TAC), specific IgM, and liver malondialdehyde (MDA) contents. The results revealed that NSO alone did not exhibit anti-Toxoplasma activity; however, when combined with PYR, it showed an efficacy similar to that of the CLN+PYR combination treatment, which enhanced survival rates, reduced parasite density, and alleviated pathological damage to the liver and spleen [186].

6. Pharmacological Applications of N. sativa

Nigella sativa seeds are rich in diverse compounds that exert metabolic effects on the human body. These seeds comprise a wide range of terpenes and terpenoids, including longipinene, longifolene, transcarbophyllene, β-caryophyllene, zonarene, and many others, each contributing to its overall pharmacological potential [147].
Investigations of the chemical profile of N. sativa for medicinal use have reported that TQ is the most multifaceted therapeutic compound. Phytosterols, such as stigmasterol, campesterol, cholesterol, β-sitosterol, and Δ5-avenasterol, enhance the complexity of the N. sativa chemical composition. Alkaloids, namely, nigellicine, nigellicimine, and nigellamines A1–A5, further enrich the biochemical diversity of plants. Tocols, including alpha-tocopherol, beta-tocopherol, and gamma-tocopherol, contribute to the antioxidant potential of N. sativa. The polyphenolic composition, which includes quercitrin, kaempferol, caftaric acid, and a spectrum of other compounds, contributes to the overall health-promoting attributes of the plant. This intricate blend of bioactive compounds in N. sativa highlights its pharmacological potential and warrants thorough investigation in the context of natural product pharmacology. A detailed understanding of these compounds provides a solid foundation for further research exploring the application of plants in various therapeutic domains [88,187,188,189]. The pharmacological characteristics of black cumin seed extract, specifically its major bioactive component, TQ, have been documented to exhibit a wide array of effects, including anti-inflammatory, antioxidant, antimicrobial, immunomodulatory, neuroprotective, cardioprotective, and anti-cancer activities [190].

6.1. Anti-Inflammatory Drug

Nigella sativa oil and TQ exhibit potent anti-inflammatory properties, as demonstrated in various disease models, such as encephalomyelitis, colitis, peritonitis, edema, and arthritis. These effects are attributed to suppression of “inflammatory mediators”, such as prostaglandins and leukotrienes [191], and in a study involving rats, oral administration of 4 mL/kg/day of N. sativa oil for 31 days resulted in reduced production of IL-4 and NO [192]. Administration of TQ at 10 mg/kg showed anti-inflammatory activity by inhibiting cyclooxygenase (COX) and 5-lipooxygenase (5-LPO) pathways in rats [193,194]. Another study found that a 5 mg/kg dose of TQ in rats lowered TNF-α and IL-1β levels in arthritis. The anti-inflammatory activity of N. sativa has been extended to humans, as evidenced by its use in geriatric patients with osteoarthritis [195].

6.2. Strong Antioxidant

An aqueous extract (200–250 mL) administered daily for five days in a clinical study with healthy subjects led to a significant increase in erythrocyte glutathione (GSH), a non-significant increase in superoxide dismutase (SOD), and a non-significant decrease in malondialdehyde (MDA) on the sixth day. The antioxidant activity was tested in vivo [196]. Supplementation of experimental rats with N. sativa oil or TQ increased ceruloplasmin levels, an extracellular antioxidant responsible for reducing Fe2+ to Fe3+. Both NSO and TQ showed a preventive effect against radiation in renal tissues, leading to an increase in paraoxonase and a reduction in hydroperoxide lipids. N. sativa seeds reduce the total antioxidant condition and oxidative stress index in irradiated rats at the renal level [197]. Treatment of rats with black cumin oil showed antioxidant activity characterized by reduced MDA and oxidized glutathione (GSSG) levels, and an increased hydrogen donor capacity [198].

6.3. Immunoregulatory Agent

Gholamnezhad et al. studied the immunomodulatory effects of N. sativa in Wistar rats. Wistar rats injected with 10% phytohemagglutinin (PHA), N. sativa supplementation at 50 g/kg improved animal weight and enlarged the spleen, responsible for particle clearance. The antioxidant effect of N. sativa was linked to its immune-stimulant activity, as evidenced by increased levels of IL-12, stimulating the production of TNF-α, IF-γ, and CD8 in the spleen of treated rats [199].
In another experiment, mice treated with cyclophosphamide (CTX) were administered N. sativa polysaccharides (NSSP) to induce immunosuppression. This treatment protected the thymus and spleen against CTX-induced damage with an increase in lactate dehydrogenase and acid phosphatase levels, indicating immunomodulatory effects. CTX administration led to reduced antioxidant capacity, SOD and CAT activities, and increased MDA content, all of which were mitigated by NSSP administration. High-dose NSSP significantly increased IL-2, IL-4, and IL-6 levels in mouse serum, decreased TNF-α levels, and regulated cytokine levels, demonstrating immunomodulatory effects. NSSP administration also upregulated PI3K protein expression, downregulated PTEN expression, activated the PI3K/Akt signaling pathway, inhibited TLR4/NF-B expression, reduced ROS and TNF-α levels, and exerted immunomodulatory effects [200].

6.4. A Substitute for Antibiotics

Considering the pressing issue of AMR, the development of novel therapeutic agents that are effective against bacterial infections has become paramount. Numerous plants, seeds, and herbs have antibacterial properties and can be used as substitutes for antibiotics against MDR pathogens [201].
Scientists are exploring the applications of phytochemicals in food, medicine, and other industries owing to their vast nutritional and antimicrobial features. N. sativa contains a wealth of phytochemicals that can be used as alternatives to conventional antibiotic drugs. Significant antibacterial activity in the fractions of the methanolic extracts of N. sativa against a range of pathogens, including Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, has been demonstrated. MDR bacteria, such as Staphylococcus saprophyticus and S. epidermidis, are also susceptible to this inhibitory effect [202]. Further, cold-pressed N. sativa oils showed a synergistic effect when tested with antibiotics on methicillin-resistant S. aureus (MRSA), enhancing the bactericidal effect, especially in combination with ‘Augmentin’. Specifically, scanning electron microscopy revealed membrane deformation in bacterial cells [203]. After N. sativa seed oils, the liquid/aqueous extract showed antibacterial activity against both Gram-positive (Micrococcus luteus, S. aureus, and Bacillus subtilis) and Gram-negative bacteria (Agrobacterium tumefaciens, Salmonella setubal, and Enterobacter aerogenes) [204]. In turn, the n-hexane extract exhibited promising antibacterial activity against S. aureus, MTCC, S. aureus, and Salmonella typhi [205]. TQ inhibited the growth of several bacterial strains and significantly inhibited biofilm formation. When used together with antibiotics, it showed a synergistic effect against both Gram-positive and Gram-negative bacteria [206]. TQ, in the methanolic extract, and NSO (extracted and commercial) showed better inhibition of Bacillus subtilis and Bacillus licheniformis [207].
With a minimum inhibitory concentration ranging between 0.25 and 1 µL/mL, the n-butanol extract from N. sativa seeds shows strong antibacterial activity against P. aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. However, it does not work against S. aureus or E. coli. The high content of terpenoids and fatty acids in the extract is presumed to be the cause of the antibacterial action [208].

6.5. Neuroprotective Medicine

Despite the research progress described above, a lack of research on N. sativa neuroprotective benefits still prevails. According to in vitro studies, pretreatment with N. sativa oil dramatically increases the vitality of neuronal cells [209]. Furthermore, in cultured cortical neurons, the methanolic extract of black cumin seeds can regulate the release of amino acid neurotransmitters, such as glutamate, glycine, aspartate, and gamma-aminobutyric acid (GABA). Additionally, it has strong effects as an analgesic and on the central nervous system (CNS) [210,211]. Several studies have identified N. sativa and TQ as neuroprotective agents [212].

6.6. Cardioprotective Agent

A cholesterol-rich diet, oxidative stress, and hypercholesterolemia can contribute to the development of atherosclerosis, a CVD characterized by reduced elasticity and hardening of the arterial walls, potentially leading to heart strokes. Elevated serum cholesterol, LDL, and triglyceride levels are the main contributing factors to this condition [213]. According to previous studies, N. sativa dramatically lowers the serum levels of triglycerides, LDL, and cholesterol, thus improving the lipid profile [214]. A study examining the impact of TQ intake on the blood lipid profile of rabbits fed a high-cholesterol diet showed a notable reduction in the levels of total cholesterol, LDL, triglycerides, and thiobarbituric-acid-reactive substances. Concomitantly, there was an improvement in the HDL cholesterol concentration [215]. N. sativa oil reduced the serum cholesterol and triglyceride levels in normal rats by 15.5% and 22%, respectively [216].
A promising result reported of a daily dosage of 1 g of N. sativa powder for two months in humans led to a notable drop in LDL cholesterol and triglyceride levels, as well as an increase in HDL cholesterol in hypercholesterolemic individuals [217]. Another study on hypercholesterolemic patients also associated N. sativa intake with decreased cholesterol levels, indicating the potential benefits of normalizing lipid profiles and preventing heart problems [44].

6.7. Application in Cancer Treatment

Numerous studies have indicated that cancer exposure risk can be reduced by using various vegetables and fruits, and N. sativa is one such ingredient showing promising anti-cancer activity [218]. A diet containing N. sativa and honey reportedly shows protective effects against lung, colon, and skin cancers. The anti-cancer effect of N. sativa was first revealed when an improvement in the activity of natural killer cells was observed in cancer patients receiving multimodality immunotherapy [219]. The seed extract of N. sativa showed cytotoxicity against multiple cancer cell lines, such as Lewis lung sarcoma (LL/2) [220]. Further, with an IC50 value of 43 µg/mL, N. sativa oil demonstrated a substantial inhibitory impact against the human lung cancer cell line A-549 [220]. Recently, Al Sheddi et al. showed that N. sativa seed extract and oil significantly reduced the viability of human lung cancer cells and changed the shape of A-549 cells in a concentration-dependent manner [221]. In a study examining the effect of aqueous and alcoholic extracts of N. sativa on MCF-7 cells, the findings demonstrated the efficacy of black cumin extracts in deactivating and inactivating MCF-7 cell lines [222]. To evaluate the preventive effects of N. sativa oil against colon cancer, abnormal crypt foci were induced in Fischer’s rats using 1,2-dimethylhydrazine. This study revealed that black cumin oil potentially hindered post-initiation colon carcinogenesis [223].
Therefore, N. sativa is a promising natural medicinal candidate for the treatment of microbial infections, metabolic disorders, and other medical conditions. The pharmacological applications of this medicinal plant, with a focus on elucidating the mechanisms of action underlying its therapeutic effects, potential side effects, and existing clinical evidence supporting its use, are summarized in Table 5.

7. Future Perspectives

Expanding the study of bioactive substances found in N. sativa and their exceptional ability to inhibit microbial growth offers excellent prospects for advancing innovative agents with antimicrobial properties. Applying N. sativa plants as a cure for various microbial infections, metabolic disorders, and cancers provides a novel approach to effectively manage these medical conditions with the least possible side effects. Crucial progress toward potential pharmacological applications has been made by gaining insight into the antimicrobial effectiveness of N. sativa through in vivo experiments. In this context, a previous study explored the impact of N. sativa seeds on the colonization of intestinal E. coli and the morphology of the jejunal region in laying hens. One particular study focused on how N. sativa seeds influence the colonization of E. coli in the intestines and the overall structure of the jejunum in laying hens. The results showed that the application of 2% N. sativa led to optimal intestinal health by effectively reducing the presence of E. coli [255].
Moreover, research progress on the therapeutic role of N. sativa opens new prospects for scientists to discover more phytochemicals and naturally occurring compounds that may assist in treating disorders, subsequently offering better strategies to combat antimicrobial resistance, adverse effects of allopathic drugs, and other emerging challenges in disease management. A clinical study established that TQ effectively maintains the integrity of the intestinal barrier and hinders the translocation of bacteria. Administration of 10 mg of thymoquinone per kg body weight via the peritoneum in rats with intestinal obstruction, a condition associated with problems in movement and damage to the mucosal lining, significantly reduced oxidative stress and inflammatory cytokines. This protects the liver and intestines from inflammatory damage [256]. In another trial, combining 2 g of N. sativa with 40 mg of omeprazole proved highly effective in eradicating Helicobacter pylori within four weeks [257]. Recent nanotechnology advancements have enhanced the bioactivity of N. sativa compounds. Nanosuspensions improve solubility, bioavailability, and stability, leading to stronger antioxidant, antidiabetic, and antibacterial effects. These formulations offer a promising solution for targeted drug delivery and overcoming drug resistance [258].
Further research is needed to improve the efficacy of the use of plant extracts to combat infectious diseases and other health issues in terms of safety, long-term efficacy, and targeted therapy. If scientists overcome the shortcomings of these plant-based therapeutic interventions, the field of medicine will revolutionize and solve many of the major clinical problems currently faced by humanity around the world.

8. Conclusions

Our review clearly showed that N. sativa is a remarkable herb with great healing power owing to its unique chemical composition. This outstanding medicinal plant plays a vital role in the well-being of the human body by contributing to metabolic regulation, modulation of the immune function, and management of diverse infectious diseases. The use of black cumin seeds in routine food helps maintain homeostatic conditions in the body. Much research has been conducted on the clinical applications of N. sativa that has verified its great antimicrobial and therapeutic potential. This review highlighted promising avenues for harnessing the bioactivities of phytochemicals to bring novelty and improvement to the therapeutic management of medical conditions. Researchers and healthcare professionals continue to explore and harness the therapeutic potential of these compounds for a wide array of applications, highlighting the significance of N. sativa in the field of natural medicine. Further research and clinical studies are needed to fully realize the therapeutic benefits of this species and pave the way for the development of innovative and effective antimicrobial interventions.

Author Contributions

Conceptualization, M.A., A.A. and D.W.; writing—original manuscript, M.A., R.H. and A.A.; literature search, S.B., S.W.B. and M.I.; figures, S.B. and M.A.; visualization, S.W.B., M.I., A.A. and D.W.; editing and revising the manuscript, S.B., M.A., R.H., S.W.B. and M.A.G.; data curation, R.H., S.B., M.I. and M.A.G.; formal analysis, M.A., D.W., A.A. and M.A.G.; funding acquisition, D.W. All authors have read and agreed to the published version of the manuscript.

Funding

This work is supported by grants from the Intergovernmental International Scientific and Technological Innovation and Cooperation Program of The National Key R&D Program (2023YFE0199200), the National Science Foundation of China (Grant Nos. 32070662 and 32030063), and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University (YG2021ZD02).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

The computations were partially performed at the Pengcheng Lab and the Center for High-Performance Computing, Shanghai Jiao Tong University.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Yu, Z.; Tang, J.; Khare, T.; Kumar, V. The Alarming Antimicrobial Resistance in ESKAPEE Pathogens: Can Essential Oils Come to the Rescue? Fitoterapia 2020, 140, 104433. [Google Scholar] [CrossRef]
  2. Watkins, R.R.; Bonomo, R.A. Overview: The Ongoing Threat of Antimicrobial Resistance. Infect. Dis. Clin. 2020, 34, 649–658. [Google Scholar] [CrossRef]
  3. Koulenti, D.; Fragkou, P.C.; Tsiodras, S. Editorial for Special Issue “Multidrug-Resistant Pathogens”. Microorganisms 2020, 8, 1383. [Google Scholar] [CrossRef]
  4. None, T.L.I.D. Antibiotic Research Priorities: Ready, Set, Now Go. Lancet Infect. Dis. 2017, 17, 349. [Google Scholar] [CrossRef]
  5. Allen, H.K. Alternatives to Antibiotics: Why and How. In NAM Perspectives; National Academy of Medicine: Washington, DC, USA, 2017. [Google Scholar] [CrossRef]
  6. Karkenny, G.; Pao, M.; Demissie, S.; Shah, N.; Hirsch, B. 2200. The Antibiotic Steward’s Nightmare: Long-Term Antibiotics in An Infectious Disease Practice. In Open Forum Infectious Diseases; Oxford University Press: New York, NY, USA, 2023; Volume 10. [Google Scholar] [CrossRef]
  7. Nikmaram, A. Intestinal Side Effects of Improper Antibiotic Use: Cause, Symptoms, and Treatment Through Probiotic Food Sources. J. Rep. Pharm. Sci. 2022, 11, 12–17. [Google Scholar] [CrossRef]
  8. Gilani, A.H.; Jabeen, Q.; Khan, M.A.U. A Review of Medicinal Uses and Pharmacological Activities of Nigella sativa. Pak. J. Biol. Sci. 2004, 7, 441–451. [Google Scholar]
  9. Chakrapani, I.; Anisree, S.; Karthika, V.; Kamesh, V.V.; Medikondu, N.R.; Ismail, Y.; Aarthi, M. Exploring the Bioactive Potential, Antimicrobial Properties and Toxicity of Peptides and Proteins from Nigella sativa for Drug Discovery. Oxid. Commun. 2023, 46, 318. [Google Scholar]
  10. Matthaus, B.; Özcan, M.M. Fatty Acids, Tocopherol, and Sterol Contents of Some Nigella Species Seed Oil. Czech J. Food Sci. 2011, 29, 145–150. [Google Scholar] [CrossRef]
  11. Al-Kayssi, A.W.; Shihab, R.M.; Mustafa, S.H. Impact of Soil Water Stress on Nigellone Oil Content of Black Cumin Seeds Grown in Calcareous-Gypsifereous Soils. Agric. Water Manag. 2011, 100, 46–57. [Google Scholar] [CrossRef]
  12. Aziz, S.A.; Kurniawati, A.; Faridah, D.N. Changes of Thymoquinone, Thymol, and Malondialdehyde Content of Black Cumin (Nigella sativa L.) in Response to Indonesia Tropical Altitude Variation. Hayati J. Biosci. 2017, 24, 156–161. [Google Scholar]
  13. Bassim Atta, M. Some Characteristics of Nigella (Nigella sativa L.) Seed Cultivated in Egypt and Its Lipid Profile. Food Chem. 2003, 83, 63–68. [Google Scholar] [CrossRef]
  14. Kabbashi, A.S.; Garbi, M.I.; El-badri, E.; Dahab, M.M.; Koko, W.S.; Abuzeid, N. Antigiardial and Cytotoxicity of Ethanolic Seed Extract of Nigella sativa (Linn) in Sudan. J. For. Prod. Ind. 2015, 4, 66–72. [Google Scholar]
  15. Asdadi, A.; Harhar, H.; Gharby, S.; Bouzoubaâ, Z.; Yadini, A.; Moutaj, R.; Hadek, M.; Chebli, B.; Hassani, L.M.I. Chemical Composition and Antifungal Activity of Nigella sativa L. Oil Seed Cultivated in Morocco. Int. J. Pharm. Sci. Invent. 2014, 3, 09–15. [Google Scholar]
  16. Ali, B.; Blunden, G. Pharmacological and Toxicological Properties of Nigella sativa. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2003, 17, 299–305. [Google Scholar] [CrossRef]
  17. Cheikh-Rouhou, S.; Besbes, S.; Hentati, B.; Blecker, C.; Deroanne, C.; Attia, H. Nigella sativa L.: Chemical Composition and Physicochemical Characteristics of Lipid Fraction. Food Chem. 2007, 101, 673–681. [Google Scholar] [CrossRef]
  18. Mollafilabi, A.; Moodi, H.; Rashed, M.H.; Kafi, M. Effect of plant density and nitrogen on yield and yield components of black cumin (Nigella sativa L.). Acta Hortic. 2010, 853, 115–126. [Google Scholar] [CrossRef]
  19. Hamrouni-Sellami, I.; Elyes Kchouk, M.; Marzouk, B. Lipid and Aroma Composition of Black Cumin (Nigella sativa L.) Seeds from Tunisia. J. Food Biochem. 2008, 32, 335–352. [Google Scholar] [CrossRef]
  20. Ainane, T.; Gharby, S.; Talbi, M.; Abourriche, A.; Bennamara, A.; Oukkache, N.; Lamdini, H.; Elkouali, M. Moroccan Formulation of Oils for the Care of Hair: Chemical Composition and Antibacterial Activity. SOJ Biochem. 2016, 10, 2376–4589. [Google Scholar] [CrossRef]
  21. Sultan, I.; Qaddoumi, I.; Yaser, S.; Rodriguez-Galindo, C.; Ferrari, A. Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients. J. Clin. Oncol. 2009, 27, 3391–3397. [Google Scholar] [CrossRef]
  22. Ali, M.; Sterk, G.; Seeger, M.; Boersema, M.; Peters, P. Effect of Hydraulic Parameters on Sediment Transport Capacity in Overland Flow over Erodible Beds. Hydrol. Earth Syst. Sci. 2012, 16, 591–601. [Google Scholar] [CrossRef]
  23. Al-Naqeep, G.; Ismail, M.; Yazan, L.S. Effects of Thymoquinone Rich Fraction and Thymoquinone on Plasma Lipoprotein Levels and Hepatic Low Density Lipoprotein Receptor and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Genes Expression. J. Funct. Foods 2009, 1, 298–303. [Google Scholar] [CrossRef]
  24. Al-Jassir, M.S. Chemical Composition and Microflora of Black Cumin (Nigella sativa L.) Seeds Growing in Saudi Arabia. Food Chem. 1992, 45, 239–242. [Google Scholar] [CrossRef]
  25. Aziz, M.A.; Khan, A.H.; Adnan, M.; Izatullah, I. Traditional Uses of Medicinal Plants Reported by the Indigenous Communities and Local Herbal Practitioners of Bajaur Agency, Federally Administrated Tribal Areas, Pakistan. J. Ethnopharmacol. 2017, 198, 268–281. [Google Scholar] [CrossRef]
  26. Salehi, B.; Quispe, C.; Imran, M.; Ul-Haq, I.; Živković, J.; Abu-Reidah, I.M.; Sen, S.; Taheri, Y.; Acharya, K.; Azadi, H.; et al. Nigella Plants—Traditional Uses, Bioactive Phytoconstituents, Preclinical and Clinical Studies. Front. Pharmacol. 2021, 12, 625386. [Google Scholar] [CrossRef]
  27. Jankowski, G.; Sawicki, R.; Truszkiewicz, W.; Wolan, N.; Ziomek, M.; Hryć, B.; Sieniawska, E. Molecular Insight into Thymoquinone Mechanism of Action against Mycobacterium Tuberculosis. Front. Microbiol. 2024, 15, 1353875. [Google Scholar] [CrossRef]
  28. Mohammad, M.Y.; Haniffa, H.M.; Choudhary, M.I. Antibacterial Activity of Thymoquinone Derivative. BMC Res. Notes 2023, 16, 260. [Google Scholar] [CrossRef]
  29. Abdul-Rahman, N.Z.; Mohd-Zubri, N.S. Therapeutic Potential of Nigella sativa. In Biochemistry, Nutrition, and Therapeutics of Black Cumin Seed; Elsevier: Amsterdam, The Netherlands, 2023; pp. 127–142. [Google Scholar]
  30. Ahmad, A.; Husain, A.; Mujeeb, M.; Khan, S.A.; Najmi, A.K.; Siddique, N.A.; Damanhouri, Z.A.; Anwar, F. A Review on Therapeutic Potential of Nigella sativa: A Miracle Herb. Asian Pac. J. Trop. Biomed. 2013, 3, 337–352. [Google Scholar] [CrossRef]
  31. Tavakoli, M.; Tavakoli, H.; Rajabipour, A.; Ahmadi, H.; Gharib-Zahedi, S.M.T. Moisture-Dependent Physical Properties of Barley Grains. Int. J. Agric. Biol. Eng. 2010, 2, 84–91. [Google Scholar]
  32. Alyami, H.H.; Al-Hariri, M.T. Synergistic effects of nigella sativa and exercise on diabetic profiles: A systematic review. Diabetes Therapy 2023, 3, 467–478. [Google Scholar] [CrossRef]
  33. Sayeed, M.S.B.; Asaduzzaman, M.; Morshed, H.; Hossain, M.M.; Kadir, M.F.; Rahman, M.R. The Effect of Nigella sativa Linn. Seed on Memory, Attention and Cognition in Healthy Human Volunteers. J. Ethnopharmacol. 2013, 148, 780–786. [Google Scholar] [CrossRef]
  34. Koshak, A.; Koshak, E.; Heinrich, M. Medicinal Benefits of Nigella sativa in Bronchial Asthma: A Literature Review. Saudi Pharm. J. 2017, 25, 1130–1136. [Google Scholar] [CrossRef]
  35. Mehta, B.K.; Sharma, U.; Agrawal, S.; Pandit, V.; Joshi, N.; Gupta, M. Isolation and Characterization of New Compounds from Seeds of Nigella sativa. Med. Chem. Res. 2008, 17, 462–473. [Google Scholar] [CrossRef]
  36. Ramadan, M.F. Introduction to Black Cumin (Nigella sativa): Chemistry, Technology, Functionality and Applications. In Black cumin (Nigella sativa) Seeds: Chemistry, Technology, Functionality, and Applications; Fawzy Ramadan, M., Ed.; Springer International Publishing: Cham, Switzerland, 2021; pp. 1–7. [Google Scholar]
  37. Salman, M.T.; Khan, R.A.; Shukla, I. Antimicrobial Activity of Nigella sativa Linn. Seed Oilagainst Multi-Drug Resistant Bacteria from Clinical Isolates. Indian J. Nat. Prod. Resour. 2008, 7, 10–14. [Google Scholar]
  38. Kmail, A.; Said, O.; Saad, B. How Thymoquinone from Nigella sativa Accelerates Wound Healing through Multiple Mechanisms and Targets. Curr. Issues Mol. Biol. 2023, 45, 9039–9059. [Google Scholar] [CrossRef]
  39. Gholamnezhad, Z.; Havakhah, S.; Boskabady, M.H. Preclinical and Clinical Effects of Nigella sativa and Its Constituent, Thymoquinone: A Review. J. Ethnopharmacol. 2016, 190, 372–386. [Google Scholar] [CrossRef]
  40. Pramanik, A.; Datta, A.K.; Gupta, S.; Basu, S.; Das, D.; Ghosh, B. Cytotoxicity Assessment of Heavy Metal Arsenic (Arsenic Trioxide) Using Nigella sativa L.(Black Cumin) as Test System. Cytologia 2019, 84, 215–219. [Google Scholar] [CrossRef]
  41. Shady, N.H.; Sobhy, S.K.; Mostafa, Y.A.; Yahia, R.; Glaeser, S.P.; Kämpfer, P.; El-Katatny, M.H.; Abdelmohsen, U.R. Phytochemical Analysis and Anti-Infective Potential of Fungal Endophytes Isolated from Nigella sativa Seeds. BMC Microbiol. 2023, 23, 343. [Google Scholar] [CrossRef]
  42. Rao, M.V.; Al-Marzouqi, A.H.; Kaneez, F.S.; Ashraf, S.S.; Adem, A. Comparative Evaluation of SFE and Solvent Extraction Methods on the Yield and Composition of Black Seeds (Nigella sativa). J. Liq. Chromatogr. Relat. Technol. 2007, 30, 2545–2555. [Google Scholar] [CrossRef]
  43. Tabassum, H.; Ahmad, A.; Ahmad, I.Z. Nigella sativa L. and Its Bioactive Constituents as Hepatoprotectant: A Review. Curr. Pharm. Biotechnol. 2018, 19, 43–67. [Google Scholar] [CrossRef]
  44. Shafiq, H.; Ahmad, A.; Masud, T.; Kaleem, M. Cardio-Protective and Anti-Cancer Therapeutic Potential of Nigella sativa. Iran. J. Basic Med. Sci. 2014, 17, 967–979. [Google Scholar]
  45. Shaterzadeh-Yazdi, H.; Noorbakhsh, M.-F.; Hayati, F.; Samarghandian, S.; Farkhondeh, T. Immunomodulatory and Anti-Inflammatory Effects of Thymoquinone. Cardiovasc. Haematol. Disord.-Drug Targets (Former. Curr. Drug Targets-Cardiovasc. Hematol. Disord.) 2018, 18, 52–60. [Google Scholar] [CrossRef]
  46. Randhawa, M.A. In Vitro Antituberculous Activity of Thymoquinone, an Active Principle of Nigella sativa. J. Ayub Med. Coll. Abbottabad 2011, 23, 78–81. [Google Scholar]
  47. Yi, T.; Zhu, L.; Zhu, G.-Y.; Tang, Y.-N.; Xu, J.; Fan, J.-Y.; Zhao, Z.-Z.; Chen, H.-B. HSCCC-Based Strategy for Preparative Separation of in Vivo Metabolites after Administration of an Herbal Medicine: Saussurea Laniceps, a Case Study. Sci. Rep. 2016, 6, 33036. [Google Scholar] [CrossRef]
  48. Mamun, M.; Absar, N. Major Nutritional Compositions of Black Cumin Seeds–Cultivated in Bangladesh and the Physicochemical Characteristics of Its Oil. Int. Food Res. J. 2018, 25, 2634–2639. [Google Scholar]
  49. Ghahramanloo, K.H.; Kamalidehghan, B.; Akbari Javar, H.; Teguh Widodo, R.; Majidzadeh, K.; Noordin, M.I. Comparative Analysis of Essential Oil Composition of Iranian and Indian Nigella sativa L. Extracted Using Supercritical Fluid Extraction and Solvent Extraction. Drug Des. Dev. Ther. 2017, 11, 2221–2226. [Google Scholar] [CrossRef]
  50. Pop, R.M.; Trifa, A.P.; Popolo, A.; Chedea, V.S.; Militaru, C.; Bocsan, I.C.; Buzoianu, A.D. Nigella sativa: Valuable Perspective in the Management of Chronic Diseases. Iran. J. Basic Med. Sci. 2020, 23, 699–713. [Google Scholar]
  51. Al Juhaimi, F.; Matthäus, B.; Ghafoor, K.; Elbabiker, E.F.; Ozcan, M. Fatty Acids, Tocopherols, Minerals Contents of Nigella sativa and Trigonella Foenum-Graecum Seed and Seed Oils. Riv. Ital. Delle Sostanze Grasse 2016, 93, 165–171. [Google Scholar]
  52. Selin, I.; Kartal, M.; Erdem, S.A. Quantitative Analysis of Thymoquinone in Nigella sativa L.(Black Cumin) Seeds and Commercial Seed Oils and Seed Oil Capsules from Turkey. J. Fac. Pharm. Ank. Univ. 2017, 41. [Google Scholar] [CrossRef]
  53. Tavakkoli, A.; Mahdian, V.; Razavi, B.M.; Hosseinzadeh, H. Review on Clinical Trials of Black Seed (Nigella sativa) and Its Active Constituent, Thymoquinone. J. Pharmacopunct. 2017, 20, 179–193. [Google Scholar]
  54. Adamska, A.; Stefanowicz-Hajduk, J.; Ochocka, J.R. Alpha-Hederin, the Active Saponin of Nigella sativa, as an Anticancer Agent Inducing Apoptosis in the SKOV-3 Cell Line. Molecules 2019, 24, 2958. [Google Scholar] [CrossRef]
  55. Khoddami, A.; Ghazali, H.M.; Yassoralipour, A.; Ramakrishnan, Y.; Ganjloo, A. Physicochemical Characteristics of Nigella Seed (Nigella sativa L.) Oil as Affected by Different Extraction Methods. J. Am. Oil Chem. Soc. 2011, 88, 533–540. [Google Scholar] [CrossRef]
  56. Alrashidi, M.; Derawi, D.; Salimon, J.; Firdaus Yusoff, M. An Investigation of Physicochemical Properties of Nigella sativa L. Seed Oil from Al-Qassim by Different Extraction Methods. J. King Saud Univ.—Sci. 2020, 32, 3337–3342. [Google Scholar] [CrossRef]
  57. Haseena, S.; Aithal, M.; Das, K.K.; Saheb, S.H. Phytochemical Analysis of Nigella sativa and Its Effect on Reproductive System. J. Pharm. Sci. Res. 2015, 7, 514–517. [Google Scholar]
  58. Razavi, B.; Hosseinzadeh, H. A Review of the Effects of Nigella sativa L. and Its Constituent, Thymoquinone, in Metabolic Syndrome. J. Endocrinol. Investig. 2014, 37, 1031–1040. [Google Scholar] [CrossRef]
  59. AbuKhader, M.M. Thymoquinone in the Clinical Treatment of Cancer: Fact or Fiction? Pharmacogn. Rev. 2013, 7, 117–120. [Google Scholar] [CrossRef]
  60. Hosseinzadeh, H.; Taiari, S.; Nassiri-Asl, M. Effect of Thymoquinone, a Constituent of Nigella sativa L., on Ischemia–Reperfusion in Rat Skeletal Muscle. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2012, 385, 503–508. [Google Scholar] [CrossRef]
  61. Kocyigit, Y.; Atamer, Y.; Uysal, E. The Effect of Dietary Supplementation of Nigella sativa L. on Serum Lipid Profile in Rats. Saudi Med. J. 2009, 30, 893–896. [Google Scholar]
  62. Ahmad, S.; Beg, Z.H. Hypolipidemic and Antioxidant Activities of Thymoquinone and Limonene in Atherogenic Suspension Fed Rats. Food Chem. 2013, 138, 1116–1124. [Google Scholar] [CrossRef]
  63. Ali, S.; Hashim, A.; Shiekh, A.; Majid, S.; Rehman, M.U. The Cardioprotective Effect of Thymoquinone from Nigella sativa. In Black Seeds (Nigella sativa); Khan, A., Rehman, M., Eds.; Elsevier: Amsterdam, The Netherlands, 2022; pp. 239–252. ISBN 978-0-12-824462-3. [Google Scholar]
  64. Marchese, A.; Arciola, C.R.; Barbieri, R.; Silva, A.S.; Nabavi, S.F.; Tsetegho Sokeng, A.J.; Izadi, M.; Jafari, N.J.; Suntar, I.; Daglia, M.; et al. Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene. Materials 2017, 10, 947. [Google Scholar] [CrossRef]
  65. Soares, G.A.B.e.; Bhattacharya, T. Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System. Available online: https://www.cabidigitallibrary.org/doi/full/10.5555/20220063069 (accessed on 13 October 2024).
  66. Balahbib, A.; El Omari, N.; Hachlafi, N.E.L.; Lakhdar, F.; El Menyiy, N.; Salhi, N.; Mrabti, H.N.; Bakrim, S.; Zengin, G.; Bouyahya, A. Health Beneficial and Pharmacological Properties of P-Cymene. Food Chem. Toxicol. 2021, 153, 112259. [Google Scholar] [CrossRef]
  67. Abelan, U.S.; de Oliveira, A.C.; Cacoci, É.S.P.; Martins, T.E.A.; Giacon, V.M.; Velasco, M.V.R.; Lima, C.R.R.d.C. Potential Use of Essential Oils in Cosmetic and Dermatological Hair Products: A Review. J. Cosmet. Dermatol. 2022, 21, 1407–1418. [Google Scholar] [CrossRef]
  68. Zouirech, O.; Alyousef, A.A.; El Barnossi, A.; El Moussaoui, A.; Bourhia, M.; Salamatullah, A.M.; Ouahmane, L.; Giesy, J.P.; Aboul-soud, M.A.M.; Lyoussi, B.; et al. Phytochemical Analysis and Antioxidant, Antibacterial, and Antifungal Effects of Essential Oil of Black Caraway (Nigella sativa L.) Seeds against Drug-Resistant Clinically Pathogenic Microorganisms. BioMed Res. Int. 2022, 2022, 5218950. [Google Scholar] [CrossRef]
  69. Rathod, N.B.; Kulawik, P.; Ozogul, F.; Regenstein, J.M.; Ozogul, Y. Biological Activity of Plant-Based Carvacrol and Thymol and Their Impact on Human Health and Food Quality. Trends Food Sci. Technol. 2021, 116, 733–748. [Google Scholar] [CrossRef]
  70. Memar, M.Y.; Raei, P.; Alizadeh, N.; Akbari Aghdam, M.; Kafil, H.S. Carvacrol and Thymol: Strong Antimicrobial Agents against Resistant Isolates. Rev. Res. Med. Microbiol. 2017, 28, 63–68. [Google Scholar] [CrossRef]
  71. Suntres, Z.E.; Coccimiglio, J.; Alipour, M. The Bioactivity and Toxicological Actions of Carvacrol. Crit. Rev. Food Sci. Nutr. 2015, 55, 304–318. [Google Scholar] [CrossRef]
  72. Ioanna, V.; Nikolaos, P.; Panayotis, P.; Chatzopoulou-Kladara, M. Camphene, a Plant-Derived Monoterpene, Reduces Plasma Cholesterol and Triglycerides in Hyperlipidemic Rats Independently of HMG-CoA Reductase Activity. PLoS ONE 2011, 6, e20516. [Google Scholar]
  73. Forouzanfar, F.; Bazzaz, B.S.F.; Hosseinzadeh, H. Black Cumin (Nigella sativa) and Its Constituent (Thymoquinone): A Review on Antimicrobial Effects. Iran. J. Basic Med. Sci. 2014, 17, 929–938. [Google Scholar]
  74. Marsik, P.; Kokoska, L.; Landa, P.; Nepovim, A.; Soudek, P.; Vanek, T. In Vitro Inhibitory Effects of Thymol and Quinones of Nigella sativa Seeds on Cyclooxygenase-1- and -2-Catalyzed Prostaglandin E2 Biosyntheses. Planta Medica 2005, 71, 739–742. [Google Scholar] [CrossRef]
  75. Majdalawieh, A.F.; Fayyad, M.W. Recent Advances on the Anti-Cancer Properties of Nigella sativa, a Widely Used Food Additive. J. Ayurveda Integr. Med. 2016, 7, 173–180. [Google Scholar] [CrossRef]
  76. Adam, S.H.; Mohd Nasri, N.; Kashim, M.I.A.M.; Abd Latib, E.H.; Ahmad Juhari, M.A.A.; Mokhtar, M.H. Potential Health Benefits of Nigella sativa on Diabetes Mellitus and Its Complications: A Review from Laboratory Studies to Clinical Trials. Front. Nutr. 2022, 9, 1057825. [Google Scholar] [CrossRef]
  77. de Sousa, G.M.; Cazarin, C.B.B.; Junior, M.R.M.; de Almeida Lamas, C.; Quitete, V.H.A.C.; Pastore, G.M.; Bicas, J.L. The Effect of α-Terpineol Enantiomers on Biomarkers of Rats Fed a High-Fat Diet. Heliyon 2020, 6, e03752. [Google Scholar] [CrossRef]
  78. Khaleel, C.; Tabanca, N.; Buchbauer, G. α-Terpineol, a Natural Monoterpene: A Review of Its Biological Properties. Open Chem. 2018, 16, 349–361. [Google Scholar] [CrossRef]
  79. Burits, M.; Bucar, F. Antioxidant Activity of Nigella sativa Essential Oil. Phytother. Res. 2000, 14, 323–328. [Google Scholar] [CrossRef]
  80. Rahman, M.T. Potential Benefits of Combination of Nigella sativa and Zn Supplements to Treat COVID-19. J. Herb. Med. 2020, 23, 100382. [Google Scholar] [CrossRef]
  81. Akram Khan, M.; Afzal, M. Chemical Composition of Nigella sativa Linn: Part 2 Recent Advances. Inflammopharmacology 2016, 24, 67–79. [Google Scholar] [CrossRef]
  82. Banerjee, A.; Kanwar, M.; Mohapatra, P.K.D.; Saso, L.; Nicoletti, M.; Maiti, S. Nigellidine (Nigella sativa, Black-Cumin Seed) Docking to SARS CoV-2 Nsp3 and Host Inflammatory Proteins May Inhibit Viral Replication/Transcription and FAS-TNF Death Signal via TNFR 1/2 Blocking. Nat. Prod. Res. 2022, 36, 5817–5822. [Google Scholar] [CrossRef]
  83. Maiti, S.; Banerjee, A.; Nazmeen, A.; Kanwar, M.; Das, S. Active-Site Molecular Docking of Nigellidine with Nucleocapsid–NSP2–MPro of COVID-19 and to Human IL1R–IL6R and Strong Antioxidant Role of Nigella sativa in Experimental Rats. J. Drug Target. 2022, 30, 511–521. [Google Scholar] [CrossRef]
  84. Niu, Y.; Zhou, L.; Meng, L.; Chen, S.; Ma, C.; Liu, Z.; Kang, W. Recent Progress on Chemical Constituents and Pharmacological Effects of the Genus Nigella. Evid.-Based Complement. Altern. Med. 2020, 2020, 6756835. [Google Scholar] [CrossRef]
  85. Nie, L.; Song, H.; He, A.; Yao, S. Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases. Curr. Top. Med. Chem. 2016, 16, 2605–2624. [Google Scholar] [CrossRef]
  86. Morikawa, T. Pharmaceutical Food Science: Search for Bio-Functional Molecules Obtained from Natural Resources to Prevent and Ameliorate Lifestyle Diseases. Chem. Pharm. Bull. 2023, 71, 756–765. [Google Scholar] [CrossRef]
  87. Gao, X.; Tang, B.; Liang, H.; Yi, L.; Wei, Z. The Protective Effect of Nigeglanine on Dextran Sulfate Sodium-Induced Experimental Colitis in Mice and Caco-2 Cells. J. Cell. Physiol. 2019, 234, 23398–23408. [Google Scholar] [CrossRef]
  88. Hossain, M.S.; Sharfaraz, A.; Dutta, A.; Ahsan, A.; Masud, M.A.; Ahmed, I.A.; Goh, B.H.; Urbi, Z.; Sarker, M.M.R.; Ming, L.C. A Review of Ethnobotany, Phytochemistry, Antimicrobial Pharmacology and Toxicology of Nigella sativa L. Biomed. Pharmacother. 2021, 143, 112182. [Google Scholar] [CrossRef]
  89. Khoshnam, S.E.; Sarkaki, A.; Rashno, M.; Farbood, Y. Memory Deficits and Hippocampal Inflammation in Cerebral Hypoperfusion and Reperfusion in Male Rats: Neuroprotective Role of Vanillic Acid. Life Sci. 2018, 211, 126–132. [Google Scholar] [CrossRef]
  90. Bai, F.; Fang, L. Vanillic Acid Mitigates the Ovalbumin (OVA)-Induced Asthma in Rat Model through Prevention of Airway Inflammation|Bioscience, Biotechnology, and Biochemistry|Oxford Academic. Available online: https://academic.oup.com/bbb/article-abstract/83/3/531/5920314 (accessed on 13 October 2024).
  91. Sharma, N.; Tiwari, N.; Vyas, M.; Khurana, N.; Muthuraman, A.; Utreja, P. An overview of therapeutic effects of vanillic acid. Plant Arch. 2020, 20, 3053–3059. [Google Scholar]
  92. Sun, L.; Ren, J.; Feng, X.; Li, S.; Wang, Y.; Jiang, Y.; Zheng, C. Caffeic Acid Markedly Induced Apoptosis of Human Multiple Myeloma Cells through the Caspase-Dependent Pathway. Pharmacogn. Mag. 2023, 19, 720–726. [Google Scholar] [CrossRef]
  93. Espíndola, K.M.M.; Ferreira, R.G.; Narvaez, L.E.M.; Silva Rosario, A.C.R.; da Silva, A.H.M.; Silva, A.G.B.; Vieira, A.P.O.; Monteiro, M.C. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma. Front. Oncol. 2019, 9, 541. [Google Scholar] [CrossRef]
  94. Elkady, A.I.; Abu-Zinadah, O.A.; El Hamid Hussein, R.A. Crude Flavonoid Extract of the Medicinal Herb Nigella sativa Inhibits Proliferation and Induces Apoptosis in Breast Cancer Cells. J. Biomater. Tissue Eng. 2017, 7, 1235–1249. [Google Scholar] [CrossRef]
  95. Veeramani, S.; Narayanan, A.P.; Yuvaraj, K.; Sivaramakrishnan, R.; Pugazhendhi, A.; Rishivarathan, I.; Jose, S.P.; Ilangovan, R. Nigella sativa Flavonoids Surface Coated Gold NPs (Au-NPs) Enhancing Antioxidant and Anti-Diabetic Activity. Process Biochem. 2022, 114, 193–202. [Google Scholar] [CrossRef]
  96. Cheng, A.-W.; Tan, X.; Sun, J.-Y.; Gu, C.-M.; Liu, C.; Guo, X. Catechin Attenuates TNF-α Induced Inflammatory Response via AMPK-SIRT1 Pathway in 3T3-L1 Adipocytes. PLoS ONE 2019, 14, e0217090. [Google Scholar] [CrossRef]
  97. Pop, R.M.; Vassilopoulou, E.; Jianu, M.-E.; Roșian, Ș.H.; Taulescu, M.; Negru, M.; Bercian, C.; Boarescu, P.-M.; Bocsan, I.C.; Feketea, G.; et al. Nigella sativa Oil Attenuates Inflammation and Oxidative Stress in Experimental Myocardial Infarction. BMC Complement. Med. Ther. 2024, 24, 362. [Google Scholar] [CrossRef]
  98. Soleimanifar, M.; Niazmand, R.; Jafari, S.M. Evaluation of Oxidative Stability, Fatty Acid Profile, and Antioxidant Properties of Black Cumin Seed Oil and Extract. Food Meas. 2019, 13, 383–389. [Google Scholar] [CrossRef]
  99. Carta, G.; Murru, E.; Banni, S.; Manca, C. Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. Front. Physiol. 2017, 8, 902. [Google Scholar] [CrossRef]
  100. Bunn, R.C.; Cockrell, G.E.; Ou, Y.; Thrailkill, K.M.; Lumpkin, C.K.; Fowlkes, J.L. Palmitate and Insulin Synergistically Induce IL-6 Expression in Human Monocytes. Cardiovasc. Diabetol. 2010, 9, 73. [Google Scholar] [CrossRef]
  101. Cheng, L.; Yu, Y.; Szabo, A.; Wu, Y.; Wang, H.; Camer, D.; Huang, X.-F. Palmitic Acid Induces Central Leptin Resistance and Impairs Hepatic Glucose and Lipid Metabolism in Male Mice. J. Nutr. Biochem. 2015, 26, 541–548. [Google Scholar] [CrossRef]
  102. Aydin, E.; Kart, A. Health Promoting Activities of Nigella sativa Seeds. In Black Cumin (Nigella sativa) Seeds: Chemistry, Technology, Functionality, and Applications; Fawzy Ramadan, M., Ed.; Springer International Publishing: Cham, Switzerland, 2021; pp. 153–177. [Google Scholar]
  103. Sharma, P.; Longvah, T. Nigella (Nigella sativa) Seed. In Oilseeds: Health Attributes and Food Applications; Tanwar, B., Goyal, A., Eds.; Springer: Singapore, 2021; pp. 331–350. ISBN 9789811541940. [Google Scholar]
  104. Abd-Rabou, A.A.; Edris, A.E. Cytotoxic, Apoptotic, and Genetic Evaluations of Nigella sativa Essential Oil Nanoemulsion against Human Hepatocellular Carcinoma Cell Lines. Cancer Nanotechnol. 2021, 12, 28. [Google Scholar] [CrossRef]
  105. Palomer, X.; Pizarro-Delgado, J.; Barroso, E.; Vázquez-Carrera, M. Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus. Trends Endocrinol. Metab. 2018, 29, 178–190. [Google Scholar] [CrossRef]
  106. Henique, C.; Mansouri, A.; Fumey, G.; Lenoir, V.; Girard, J.; Bouillaud, F.; Prip-Buus, C.; Cohen, I. Increased Mitochondrial Fatty Acid Oxidation Is Sufficient to Protect Skeletal Muscle Cells from Palmitate-Induced Apoptosis. J. Biol. Chem. 2010, 285, 36818–36827. [Google Scholar] [CrossRef]
  107. Mei, S.; Ni, H.-M.; Manley, S.; Bockus, A.; Kassel, K.M.; Luyendyk, J.P.; Copple, B.L.; Ding, W.-X. Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in Hepatocytes. J. Pharmacol. Exp. Ther. 2011, 339, 487–498. [Google Scholar] [CrossRef]
  108. Hegazy, E.; Haggag, T.; Elmansy, M. The Protective Role of Nigella sativa versus Lepidium Sativum on the Submandibular Salivary Gland in Hypercholesterolemic Albino Rat (Histological and Immunohistochemical Study). Egypt. Dent. J. 2021, 67, 3113–3125. [Google Scholar] [CrossRef]
  109. Nazir, S.; Mobashar, A.; Anjum, I.; Chaudhary, W.A.; Tariq, N.; Dar, S.R. Mechanistic Evaluation of Anti-Arthritic Effects of Campesterol Through Downregulation of TNF-α, IL-1β, IL-6, NF-κB, MMP 3,COX I and COX II and Upregulation of IL-4. 2023. Available online: https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.researchsquare.com/article/rs-3053739/v1.pdf (accessed on 9 September 2024).
  110. Crimarco, A.; Springfield, S.; Petlura, C.; Streaty, T.; Cunanan, K.; Lee, J.; Fielding-Singh, P.; Carter, M.M.; Topf, M.A.; Wastyk, H.C.; et al. A Randomized Crossover Trial on the Effect of Plant-Based Compared with Animal-Based Meat on Trimethylamine-N-Oxide and Cardiovascular Disease Risk Factors in Generally Healthy Adults: Study With Appetizing Plantfood—Meat Eating Alternative Trial (SWAP-MEAT). Am. J. Clin. Nutr. 2020, 112, 1188–1199. [Google Scholar] [CrossRef]
  111. Brown, L.; Rose, K.; Campbell, A. Healthy Plant-Based Diets and Their Short-Term Effects on Weight Loss, Nutrient Intake and Serum Cholesterol Levels. Nutr. Bull. 2022, 47, 199–207. [Google Scholar] [CrossRef]
  112. Kiralan, M.; Kiralan, S.S.; Ozkan, G.; Ramadan, M.F. Food Applications of Nigella sativa Fixed Oil. In Black cumin (Nigella sativa) seeds: Chemistry, Technology, Functionality, and Applications; Fawzy Ramadan, M., Ed.; Springer International Publishing: Cham, Switzerland, 2021; pp. 349–360. [Google Scholar]
  113. Bakrim, S.; Benkhaira, N.; Bourais, I.; Benali, T.; Lee, L.-H.; El Omari, N.; Sheikh, R.A.; Goh, K.W.; Ming, L.C.; Bouyahya, A. Health Benefits and Pharmacological Properties of Stigmasterol. Antioxidants 2022, 11, 1912. [Google Scholar] [CrossRef]
  114. European Food Safety Authority (EFSA); Medina-Pastor, P.; Triacchini, G. The 2018 European Union Report on Pesticide Residues in Food. EFSA J. Eur. Food Saf. Auth. 2020, 18, e06057. [Google Scholar] [CrossRef]
  115. Padmasri Govindarajan, P.G.; Sarada, D.V.L. Isolation and Characterization of Stigmasterol and β-Sitosterol from Acacia Nilotica (L.) Delile Ssp. Indica (Benth.) Brenan. J. Pharm. Res. 2011, 4, 3601–3602. [Google Scholar]
  116. Somsak, N.; Peerawit, P.; Chusri, T. Hypoglycemic Activity in Diabetic Rats of Stigmasterol and Sitosterol-3-O--D-Glucopyranoside Isolated from Pseuderanthemum Palatiferum (Nees) Radlk. Leaf Extract. J. Med. Plants Res. 2015, 9, 629–635. [Google Scholar] [CrossRef]
  117. Bae, H.; Song, G.; Lim, W. Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction. Pharmaceutics 2020, 12, 488. [Google Scholar] [CrossRef]
  118. Ahmad Khan, M.; Sarwar, A.H.M.G.; Rahat, R.; Ahmed, R.S.; Umar, S. Stigmasterol Protects Rats from Collagen Induced Arthritis by Inhibiting Proinflammatory Cytokines. Int. Immunopharmacol. 2020, 85, 106642. [Google Scholar] [CrossRef]
  119. Wen, S.; He, L.; Zhong, Z.; Zhao, R.; Weng, S.; Mi, H.; Liu, F. Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis. Front. Immunol. 2021, 12, 741934. [Google Scholar] [CrossRef]
  120. Sun, J.; Li, X.; Liu, J.; Pan, X.; Zhao, Q. Stigmasterol Exerts Neuro-Protective Effect Against Ischemic/Reperfusion Injury Through Reduction Of Oxidative Stress And Inactivation Of Autophagy. Neuropsychiatr. Dis. Treat. 2019, 15, 2991–3001. [Google Scholar] [CrossRef]
  121. Ayele, T.T.; Gurmessa, G.T.; Abdissa, Z.; Kenasa, G.; Abdissa, N. Oleanane and Stigmasterol-Type Triterpenoid Derivatives from the Stem Bark of Albizia Gummifera and Their Antibacterial Activities. J. Chem. 2022, 2022, 9003143. [Google Scholar] [CrossRef]
  122. Bourgou, S.; Pichette, A.; Marzouk, B.; Legault, J. Antioxidant, Anti-Inflammatory, Anticancer and Antibacterial Activities of Extracts from Nigella sativa (Black Cumin) Plant Parts. J. Food Biochem. 2012, 36, 539–546. [Google Scholar] [CrossRef]
  123. Esharkawy, E.R.; Almalki, F.; Hadda, T.B. In Vitro Potential Antiviral SARS-CoV-19-Activity of Natural Product Thymohydroquinone and Dithymoquinone from Nigella sativa. Bioorg. Chem. 2022, 120, 105587. [Google Scholar] [CrossRef]
  124. Song, J.; Yeo, S.-G.; Hong, E.-H.; Lee, B.-R.; Kim, J.-W.; Kim, J.; Jeong, H.; Kwon, Y.; Kim, H.; Lee, S.; et al. Antiviral Activity of Hederasaponin B from Hedera Helix against Enterovirus 71 Subgenotypes C3 and C4a. Biomol. Ther. 2014, 22, 41–46. [Google Scholar] [CrossRef]
  125. Lima, I.O.; Pereira, F.D.O.; Oliveira, W.A.D.; Lima, E.D.O.; Menezes, E.A.; Cunha, F.A.; Diniz, M.D.F.F.M. Antifungal Activity and Mode of Action of Carvacrol against Candida Albicans Strains. J. Essent. Oil Res. 2013, 25, 138–142. [Google Scholar] [CrossRef]
  126. Šegvić Klarić, M.; Kosalec, I.; Mastelić, J.; Pieckova, E.; Pepeljnak, S. Antifungal Activity of Thyme (Thymus vulgaris L.) Essential Oil and Thymol against Moulds from Damp Dwellings. Lett. Appl. Microbiol. 2007, 44, 36–42. [Google Scholar] [CrossRef]
  127. Rattanachaikunsopon, P.; Phumkhachorn, P. In Vitro Study of Synergistic Antimicrobial Effect of Carvacrol and Cymene on Drug Resistant Salmonella Typhi. Afr. J. Microbiol. Res 2009, 3, 978–980. [Google Scholar]
  128. Thakre, A.D.; Mulange, S.V.; Kodgire, S.S.; Zore, G.B.; Karuppayil, S.M. Effects of Cinnamaldehyde, Ocimene, Camphene, Curcumin and Farnesene on Candida Albicans. Adv. Microbiol. 2016, 6, 627–643. [Google Scholar] [CrossRef]
  129. Usman, R.A.; Idris, M.M.; Makinde, S.A. Antibacterial Activity of Nigella sativa Seed Extracts. Bayero J. Pure Appl. Sci. 2017, 10, 328–330. [Google Scholar] [CrossRef]
  130. Pohl, C.H.; Kock, J.L.; Thibane, V.S. Antifungal Free Fatty Acids: A Review. Sci. Against Microb. Pathog. Commun. Curr. Res. Technol. Adv. 2011, 1, 61–71. [Google Scholar]
  131. Tan, L.F.; Yap, V.L.; Rajagopal, M.; Wiart, C.; Selvaraja, M.; Leong, M.Y.; Tan, P.L. Plant as an Alternative Source of Antifungals against Aspergillus Infections: A Review. Plants 2022, 11, 3009. [Google Scholar] [CrossRef]
  132. Shokry, S.; Hegazy, A.; Abbas, A.M.; Mostafa, I.; Eissa, I.H.; Metwaly, A.M.; Yahya, G.; El-Shazly, A.M.; Aboshanab, K.M.; Mostafa, A. Phytoestrogen β-Sitosterol Exhibits Potent in Vitro Antiviral Activity against Influenza a Viruses. Vaccines 2023, 11, 228. [Google Scholar] [CrossRef]
  133. Beavers, W.N.; Monteith, A.J.; Amarnath, V.; Mernaugh, R.L.; Roberts, L.J.; Chazin, W.J.; Davies, S.S.; Skaar, E.P. Arachidonic Acid Kills Staphylococcus Aureus through a Lipid Peroxidation Mechanism. mBio 2019, 10, e01333-19. [Google Scholar] [CrossRef]
  134. Yang, T.-L.; Hsieh, C.-M.; Meng, L.-J.; Tsai, T.; Chen, C.-T. Oleic Acid-Based Self Micro-Emulsifying Delivery System for Enhancing Antifungal Activities of Clotrimazole. Pharmaceutics 2022, 14, 478. [Google Scholar] [CrossRef]
  135. Mpanju, O. Mechanisms of [Gamma]-Linolenic Acid Induction of Apoptosis in T Cells Chronically Infected with HIV-1. Ph.D. Thesis, University of British Columbia, Vancouver, BC, Canada, 2001. [Google Scholar]
  136. de Oliveira Pereira, F.; Mendes, J.M.; de Oliveira Lima, E. Investigation on Mechanism of Antifungal Activity of Eugenol against Trichophyton Rubrum. Med. Mycol. 2013, 51, 507–513. [Google Scholar] [CrossRef]
  137. Tucker, J.M.; Townsend, D.M. Alpha-Tocopherol: Roles in Prevention and Therapy of Human Disease. Biomed. Pharmacother. 2005, 59, 380–387. [Google Scholar] [CrossRef]
  138. Jiang, Q.; Ames, B.N. γ-Tocopherol, but Not A-tocopherol, Decreases Proinflammatory Eicosanoids and Inflammation Damage in Rats. FASEB J. 2003, 17, 816–822. [Google Scholar] [CrossRef]
  139. Ahmad, M.F.; Ahmad, F.A.; Ashraf, S.A.; Saad, H.H.; Wahab, S.; Khan, M.I.; Ali, M.; Mohan, S.; Hakeem, K.R.; Athar, M.T. An Updated Knowledge of Black Seed (Nigella sativa Linn.): Review of Phytochemical Constituents and Pharmacological Properties. J. Herb. Med. 2021, 25, 100404. [Google Scholar] [CrossRef]
  140. Khalife, K.; Lupidi, G. Nonenzymatic Reduction of Thymoquinone in Physiological Conditions. Free Radic. Res. 2007, 41, 153–161. [Google Scholar] [CrossRef]
  141. Hadi, V.; Kheirouri, S.; Alizadeh, M.; Khabbazi, A.; Hosseini, H. Effects of Nigella sativa Oil Extract on Inflammatory Cytokine Response and Oxidative Stress Status in Patients with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Avicenna J. Phytomed. 2016, 6, 34–43. [Google Scholar]
  142. Mor, A.; Abramson, S.B.; Pillinger, M.H. The Fibroblast-like Synovial Cell in Rheumatoid Arthritis: A Key Player in Inflammation and Joint Destruction. Clin. Immunol. 2005, 115, 118–128. [Google Scholar] [CrossRef]
  143. Bordoni, L.; Fedeli, D.; Nasuti, C.; Maggi, F.; Papa, F.; Wabitsch, M.; De Caterina, R.; Gabbianelli, R. Antioxidant and Anti-Inflammatory Properties of Nigella sativa Oil in Human Pre-Adipocytes. Antioxidants 2019, 8, 51. [Google Scholar] [CrossRef]
  144. Umar, S.; Zargan, J.; Umar, K.; Ahmad, S.; Katiyar, C.K.; Khan, H.A. Modulation of the Oxidative Stress and Inflammatory Cytokine Response by Thymoquinone in the Collagen Induced Arthritis in Wistar Rats. Chem.-Biol. Interact. 2012, 197, 40–46. [Google Scholar] [CrossRef]
  145. Abdallah, E.M. Plants: An Alternative Source for Antimicrobials. J. Appl. Pharm. Sci. 2011, 1, 16–20. [Google Scholar]
  146. Omojate Godstime, C.; Enwa Felix, O.; Jewo Augustina, O.; Eze Christopher, O. Mechanisms of Antimicrobial Actions of Phytochemicals against Enteric Pathogens—A Review. J. Pharm. Chem. Biol. Sci. 2014, 2, 77–85. [Google Scholar]
  147. Shafodino, F.S.; Lusilao, J.M.; Mwapagha, L.M. Phytochemical Characterization and Antimicrobial Activity of Nigella sativa Seeds. PLoS ONE 2022, 17, e0272457. [Google Scholar] [CrossRef]
  148. Mohamed Shohayeb, M.S.; Eman Halawani, E.H. Comparative Antimicrobial Activity of Some Active Constituents of N. sativa L. World Appl. Sci. J. 2012, 20, 182–189. [Google Scholar]
  149. Aumeeruddy, M.Z.; Aumeeruddy-Elalfi, Z.; Neetoo, H.; Zengin, G.; Fibrich, B.; Rademan, S.; Van Staden, A.B.; Szuman, K.; Lambrechts, I.A.; Lall, N. Biological, Phytochemical, and Physico-Chemical Properties of Two Commercial Nigella sativa Seed Oils: A Comparative Analysis. Istanb. J. Pharm. 2019, 48, 89–99. [Google Scholar] [CrossRef]
  150. Goel, S.; Mishra, P. Thymoquinone Inhibits Biofilm Formation and Has Selective Antibacterial Activity Due to ROS Generation. Appl. Microbiol. Biotechnol. 2018, 102, 1955–1967. [Google Scholar] [CrossRef]
  151. Ishtiaq, S.; Ashraf, M.; Hayat, M.Q.; Asrar, M. Phytochemical Analysis of Nigella sativa and Its Antibacterial Activity against Clinical Isolates Identified by Ribotyping. Int. J. Agric. Biol. 2013, 15, 1151–1156. [Google Scholar]
  152. Mouwakeh, A.; Telbisz, A.; Spengler, G.; Mohacsi-Farkas, C.; Kiskó, G. Antibacterial and Resistance Modifying Activities of Nigella sativa Essential Oil and Its Active Compounds against Listeria Monocytogenes. In Vivo 2018, 32, 737–743. [Google Scholar] [CrossRef]
  153. Qian, M.; Ismail, B.B.; He, Q.; Zhang, X.; Yang, Z.; Ding, T.; Ye, X.; Liu, D.; Guo, M. Inhibitory Mechanisms of Promising Antimicrobials from Plant Byproducts: A Review. Comp. Rev. Food Sci. Food Saf. 2023, 22, 2523–2590. [Google Scholar] [CrossRef]
  154. Ghaffar, N.; Javad, S.; Shah, A.A.; Ilyas, S.; Hashem, A.; Avila-Quezada, G.D.; Abd_Allah, E.F.; Tariq, A. Restoration of Antibacterial Activity of Inactive Antibiotics via Combined Treatment with AgNPs. ACS Omega 2024, 9, 13621–13635. [Google Scholar] [CrossRef]
  155. Lönnroth, K.; Migliori, G.B.; Abubakar, I.; D’Ambrosio, L.; De Vries, G.; Diel, R.; Douglas, P.; Falzon, D.; Gaudreau, M.-A.; Goletti, D. Towards Tuberculosis Elimination: An Action Framework for Low-Incidence Countries. Eur. Respir. J. 2015, 45, 928–952. [Google Scholar] [CrossRef]
  156. Lienhardt, C.; Lönnroth, K.; Menzies, D.; Balasegaram, M.; Chakaya, J.; Cobelens, F.; Cohn, J.; Denkinger, C.M.; Evans, T.G.; Källenius, G. Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions. PLoS Med. 2016, 13, e1001965. [Google Scholar] [CrossRef]
  157. Lienhardt, C.; Vernon, A.; Raviglione, M.C. New Drugs and New Regimens for the Treatment of Tuberculosis: Review of the Drug Development Pipeline and Implications for National Programmes. Curr. Opin. Pulm. Med. 2010, 16, 186–193. [Google Scholar] [CrossRef]
  158. Anbarasu, S.; Sundar, R.; Manigundan, K.; Rajasekar, T.; Shamya, M.; Joseph, J. Evaluating the Anti-Mycobacterial Activity of Nigella sativa Seed Extracts. Sch. Res. Libr. Der Pharm. Lett. 2018, 10, 1–9. [Google Scholar]
  159. Dehyab, A.S.; Bakar, M.F.A.; Alomar, M.K.; Sabran, S.F. A Review of Medicinal Plant of Middle East and North Africa (MENA) Region as Source in Tuberculosis Drug Discovery. Saudi J. Biol. Sci. 2020, 27, 2457–2478. [Google Scholar] [CrossRef]
  160. Mahmud, H.A.; Seo, H.; Kim, S.; Islam, M.I.; Nam, K.-W.; Cho, H.-D.; Song, H.-Y. Thymoquinone (TQ) Inhibits the Replication of Intracellular Mycobacterium Tuberculosis in Macrophages and Modulates Nitric Oxide Production. BMC Complement. Altern. Med. 2017, 17, 279. [Google Scholar] [CrossRef]
  161. Dey, D.; Ray, R.; Hazra, B. Antitubercular and Antibacterial Activity of Quinonoid Natural Products against Multi-drug Resistant Clinical Isolates. Phytother. Res. 2014, 28, 1014–1021. [Google Scholar] [CrossRef]
  162. Jaswal, A.; Sinha, N.; Bhadauria, M.; Shrivastava, S.; Shukla, S. Therapeutic Potential of Thymoquinone against Anti-Tuberculosis Drugs Induced Liver Damage. Environ. Toxicol. Pharmacol. 2013, 36, 779–786. [Google Scholar] [CrossRef]
  163. Koshak, A.E.; Koshak, E.A.; Mobeireek, A.F.; Badawi, M.A.; Wali, S.O.; Malibary, H.M.; Atwah, A.F.; Alhamdan, M.M.; Almalki, R.A.; Madani, T.A. Nigella sativa for the Treatment of COVID-19: An Open-Label Randomized Controlled Clinical Trial. Complement. Ther. Med. 2021, 61, 102769. [Google Scholar] [CrossRef]
  164. Kadil, Y.; Mouhcine, M.; Filali, H. In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella sativa. Curr. Drug Discov. Technol. 2021, 18, 570–573. [Google Scholar] [CrossRef]
  165. Sommer, A.P.; Försterling, H.-D.; Sommer, K.E. Tutankhamun’s Antimalarial Drug for COVID-19. Drug Res. 2021, 71, 4–9. [Google Scholar] [CrossRef]
  166. Yadav, P.K.; Jaiswal, A.; Singh, R.K. In Silico Study on Spice-Derived Antiviral Phytochemicals against SARS-CoV-2 TMPRSS2 Target. J. Biomol. Struct. Dyn. 2022, 40, 11874–11884. [Google Scholar] [CrossRef]
  167. Ahmad, S.; Abbasi, H.W.; Shahid, S.; Gul, S.; Abbasi, S.W. Molecular Docking, Simulation and MM-PBSA Studies of Nigella sativa Compounds: A Computational Quest to Identify Potential Natural Antiviral for COVID-19 Treatment. J. Biomol. Struct. Dyn. 2021, 39, 4225–4233. [Google Scholar] [CrossRef]
  168. Sumaryada, T.; Pramudita, C.A. Molecular Docking Evaluation of Some Indonesian’s Popular Herbals for a Possible COVID-19 Treatment. Biointerface Res. Appl. Chem. 2021, 11, 9827–9835. [Google Scholar]
  169. Mehra, R.; Khan, I.A.; Nargotra, A. Anti-Tubercular Drug Discovery: In Silico Implications and Challenges. Eur. J. Pharm. Sci. 2017, 104, 1–15. [Google Scholar] [CrossRef]
  170. Vanhaelen, Q.; Mamoshina, P.; Aliper, A.M.; Artemov, A.; Lezhnina, K.; Ozerov, I.; Labat, I.; Zhavoronkov, A. Design of Efficient Computational Workflows for in Silico Drug Repurposing. Drug Discov. Today 2017, 22, 210–222. [Google Scholar] [CrossRef]
  171. Gado, A.R.; Ellakany, H.; Elbestawy, A.R.; Abd El-Hack, M.E.; Khafaga, A.F.; Taha, A.E.; Mahgoub, S. Herbal medicine additives as powerful agents to control and prevent avian influenza virus in poultry—A review. Ann. Anim. Sci. 2019, 19, 905–935. [Google Scholar] [CrossRef]
  172. Tania, M.; Asad, A.; Li, T.; Islam, M.S.; Islam, S.B.; Hossen, M.M.; Bhuiyan, M.R.; Khan, M.A. Thymoquinone against Infectious Diseases: Perspectives in Recent Pandemics and Future Therapeutics. Iran. J. Basic Med. Sci. 2021, 24, 1014–1022. [Google Scholar] [CrossRef]
  173. Ahmed, A.M.; Al-Olayan, E.M.; Aboul-Soud, M.A.; Al-Khedhairy, A.A. The Immune Enhancer, Thymoquinone, and the Hope of Utilizing the Immune System of Aedes Caspius against Disease Agents. Afr. J. Biotechnol. 2010, 9, 3183–3195. [Google Scholar]
  174. Saleem, H.N.; Batool, F.; Mansoor, H.J.; Shahzad-ul-Hussan, S.; Saeed, M. Inhibition of Dengue Virus Protease by Eugeniin, Isobiflorin, and Biflorin Isolated from the Flower Buds of Syzygium aromaticum (Cloves). ACS Omega 2019, 4, 1525–1533. [Google Scholar] [CrossRef]
  175. Ciesielska-Figlon, K.; Wojciechowicz, K.; Wardowska, A.; Lisowska, K.A. The Immunomodulatory Effect of Nigella sativa. Antioxidants 2023, 12, 1340. [Google Scholar] [CrossRef]
  176. Khan, M.A.U.; Ashfaq, M.K.; Zuberi, H.S.; Mahmood, M.S.; Gilani, A.H. The in Vivo Antifungal Activity of the Aqueous Extract from Nigella sativa Seeds. Phytother. Res. 2003, 17, 183–186. [Google Scholar] [CrossRef]
  177. Rezgui, M.; Majdoub, N.; Mabrouk, B.; Baldisserotto, A.; Bino, A.; Ben Kaab, L.B.; Manfredini, S. Antioxidant and Antifungal Activities of Marrubiin, Extracts and Essential Oil from Marrubium vulgare L. against Pathogenic Dermatophyte Strains. J. De Mycol. Médicale 2020, 30, 100927. [Google Scholar] [CrossRef]
  178. Akansha; Kaushal, S.; Arora, A.; Heena; Sharma, P.; Jangra, R. Chemical Composition and Synergistic Antifungal Potential of Nigella sativa L. Seeds and Syzygium aromaticum (L.) Merr. & L.M. Perry Buds Essential Oils and Their Major Compounds, and Associated Molecular Docking Studies. J. Essent. Oil Bear. Plants 2023, 26, 602–625. [Google Scholar] [CrossRef]
  179. Barashkova, A.S.; Sadykova, V.S.; Salo, V.A.; Zavriev, S.K.; Rogozhin, E.A. Nigellothionins from Black Cumin (Nigella sativa L.) Seeds Demonstrate Strong Antifungal and Cytotoxic Activity. Antibiotics 2021, 10, 166. [Google Scholar] [CrossRef]
  180. Benazzouz-Smail, L.; Achat, S.; Brahmi, F.; Bachir-Bey, M.; Arab, R.; Lorenzo, J.M.; Benbouriche, A.; Boudiab, K.; Hauchard, D.; Boulekbache, L.; et al. Biological Properties, Phenolic Profile, and Botanical Aspect of Nigella sativa L. and Nigella damascena L. Seeds: A Comparative Study. Molecules 2023, 28, 571. [Google Scholar] [CrossRef]
  181. Zishan, M.; Manzoor, U. Antifungal Activity of Aloe Barbadensis and Nigella sativa: A Review. Int. J. Biol. Phys. Chem. Stud. 2020, 2, 11–14. [Google Scholar]
  182. Al-Ameedy, T.H.; Omran, R. Antimicrobial Activity of Nigella sativa Extract Against Some Bacterial and Fungal Species. J. Univ. Babylon Pure Appl. Sci. 2019, 27, 277–286. [Google Scholar]
  183. Nouri, N.; Mohammadi, S.R.; Beardsley, J.; Aslani, P.; Ghaffarifar, F.; Roudbary, M.; Rodrigues, C.F. Thymoquinone Antifungal Activity against Candida Glabrata Oral Isolates from Patients in Intensive Care Units—An In Vitro Study. Metabolites 2023, 13, 580. [Google Scholar] [CrossRef]
  184. Abdulelah, H.; Zainal-Abidin, B. In Vivo Anti-Malarial Tests of Nigella sativa (Black Seed) Different Extracts. Am. J. Pharmacol. Toxicol. 2007, 2, 46–50. [Google Scholar]
  185. Sheikh, B.Y.; Taha, M.M.E.; Koko, W.S.; Abdelwahab, S.I. Antimicrobial Effects of Thymoquinone on Entamoeba Histolytica and Giardia Lamblia. Pharmacogn. J. 2015, 8, 168–170. [Google Scholar] [CrossRef]
  186. Mady, R.F.; El-Hadidy, W.; Elachy, S. Effect of Nigella sativa Oil on Experimental Toxoplasmosis. Parasitol. Res. 2016, 115, 379–390. [Google Scholar] [CrossRef]
  187. Hannan, M.A.; Rahman, M.A.; Sohag, A.A.M.; Uddin, M.J.; Dash, R.; Sikder, M.H.; Rahman, M.S.; Timalsina, B.; Munni, Y.A.; Sarker, P.P.; et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021, 13, 1784. [Google Scholar] [CrossRef]
  188. Dalli, M.; Bekkouch, O.; Azizi, S.; Azghar, A.; Gseyra, N.; Kim, B. Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019–2021). Biomolecules 2022, 12, 20. [Google Scholar] [CrossRef]
  189. Adeleke, A.E.; Onifade, A.P.; Awojide, S.H.; Adegbite, A.A. Chemical and Nutritive Composition of Nigella sativa (Black Seed) Oils. Adeleke Univ. J. Sci. 2023, 2, 94–101. [Google Scholar]
  190. Fatima Shad, K.; Soubra, W.; Cordato, D.J. The Role of Thymoquinone, a Major Constituent of Nigella sativa, in the Treatment of Inflammatory and Infectious Diseases. Clin. Exp. Pharmacol. Physiol. 2021, 48, 1445–1453. [Google Scholar] [CrossRef]
  191. Salem, M.L. Immunomodulatory and Therapeutic Properties of the Nigella sativa L. Seed. Int. Immunopharmacol. 2005, 5, 1749–1770. [Google Scholar] [CrossRef]
  192. Khaldi, T.; Chekchaki, N.; Boumendjel, M.; Taibi, F.; Abdellaoui, M.; Messarah, M.; Boumendjel, A. Ameliorating Effects of Nigella sativa Oil on Aggravation of Inflammation, Oxidative Stress and Cytotoxicity Induced by Smokeless Tobacco Extract in an Allergic Asthma Model in Wistar Rats. Allergol. Et Immunopathol. 2018, 46, 472–481. [Google Scholar] [CrossRef]
  193. Alam, M.; Galav, V. Anti-Inflammatory Effect and Toxicological Evaluation of Thymoquinone (Volatile Oil of Black Seed) on Adjuvant-Induced Arthritis in Wistar Rat. Indian J. Life Sci. 2013, 2, 17–22. [Google Scholar]
  194. Amin, B.; Hosseinzadeh, H. Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-Inflammatory Effects. Planta Medica 2015, 82, 8–16. [Google Scholar] [CrossRef]
  195. Tuna, H.I.; Babadag, B.; Ozkaraman, A.; Balci Alparslan, G. Investigation of the Effect of Black Cumin Oil on Pain in Osteoarthritis Geriatric Individuals. Complement. Ther. Clin. Pract. 2018, 31, 290–294. [Google Scholar] [CrossRef]
  196. Bilto, Y.Y.; Alabdallat, N.G.; Atoom, A.M.; Khalaf, N.A. Effects of Commonly Used Medicinal Herbs in Jordan on Erythrocyte Oxidative Stress Markers. J. Pharm. Pharmacogn. Res. 2021, 9, 422–434. [Google Scholar] [CrossRef]
  197. Nehar, S.; Rani, P.; Kumar, C. Evaluation of Genoprotective and Antioxidative Potentiality of Ethanolic Extract of N. sativa Seed in Streptozotocin Induced Diabetic Albino Rats. Vegetos 2021, 34, 453–459. [Google Scholar] [CrossRef]
  198. Pop, R.M.; Sabin, O.; Suciu, Ș.; Vesa, S.C.; Socaci, S.A.; Chedea, V.S.; Bocsan, I.C.; Buzoianu, A.D. Nigella sativa’s Anti-Inflammatory and Antioxidative Effects in Experimental Inflammation. Antioxidants 2020, 9, 921. [Google Scholar] [CrossRef]
  199. Gholamnezhad, Z.; Boskabady, M.H.; Hosseini, M. The Effect of Chronic Supplementation of Nigella sativa on Splenocytes Response in Rats Following Treadmill Exercise. Drug Chem. Toxicol. 2021, 44, 487–492. [Google Scholar] [CrossRef]
  200. Liang, Q.; Dong, J.; Wang, S.; Shao, W.; Ahmed, A.F.; Zhang, Y.; Kang, W. Immunomodulatory Effects of Nigella sativa Seed Polysaccharides by Gut Microbial and Proteomic Technologies. Int. J. Biol. Macromol. 2021, 184, 483–496. [Google Scholar] [CrossRef]
  201. Anand, U.; Nandy, S.; Mundhra, A.; Das, N.; Pandey, D.K.; Dey, A. A Review on Antimicrobial Botanicals, Phytochemicals and Natural Resistance Modifying Agents from Apocynaceae Family: Possible Therapeutic Approaches against Multidrug Resistance in Pathogenic Microorganisms. Drug Resist. Updates 2020, 51, 100695. [Google Scholar] [CrossRef]
  202. Adebayo-Tayo, B.C.; Briggs-Kamara, A.I.; Salaam, A. Phytochemical Composition, Antioxidant, Antimicrobial Potential and Gc-Ms Analysis of Crude and Partitioned Fractions of Nigella sativa Seed Extract. Acta Microbiol. Bulg 2021, 37, 34–45. [Google Scholar]
  203. Badger-Emeka, L.I.; Emeka, P.M.; Ibrahim, H.I.M. A Molecular Insight into the Synergistic Mechanism of Nigella sativa (Black Cumin) with β-Lactam Antibiotics against Clinical Isolates of Methicillin-Resistant Staphylococcus Aureus. Appl. Sci. 2021, 11, 3206. [Google Scholar] [CrossRef]
  204. Arif, S.; Saqib, H.; Mubashir, M.; Malik, S.I.; Mukhtar, A.; Saqib, S.; Ullah, S.; Show, P.L. Comparison of Nigella sativa and Trachyspermum Ammi via Experimental Investigation and Biotechnological Potential. Chem. Eng. Process.—Process Intensif. 2021, 161, 108313. [Google Scholar] [CrossRef]
  205. Raveesha, K.A. Antibacterial Activity and Time-Kill Assay of Terminalia Catappa L. and Nigella sativa L. against Selected Human Pathogenic Bacteria. J. Pure Appl. Microbiol. 2021, 15, 285–299. [Google Scholar]
  206. Dera, A.A.; Ahmad, I.; Rajagopalan, P.; Al Shahrani, M.; Saif, A.; Alshahrani, M.Y.; Alraey, Y.; Alamri, A.M.; Alasmari, S.; Makkawi, M. Synergistic Efficacies of Thymoquinone and Standard Antibiotics against Multi-Drug Resistant Isolates. Saudi Med. J. 2021, 42, 196–204. [Google Scholar] [CrossRef]
  207. Habib, N.; Choudhry, S. HPLC Quantification of Thymoquinone Extracted from Nigella sativa L.(Ranunculaceae) Seeds and Antibacterial Activity of Its Extracts against Bacillus Species. Evid.-Based Complement. Altern. Med. 2021, 2021, 6645680. [Google Scholar] [CrossRef]
  208. Nazarparvar, M.; Shakeri, A.; Ranjbariyan, A. Chemical Composition and Antimicrobial Activity against Food Poisoning of Alcoholic Extract of Nigella sativa L. Biointerface Res. Appl. Chem. 2020, 10, 6991–7001. [Google Scholar]
  209. Ismail, N.; Ismail, M.; Latiff, L.A.; Mazlan, M.; Mariod, A.A. Black Cumin Seed (Nigella sativa Linn.) Oil and Its Fractions Protect against Beta Amyloid Peptide-induced Toxicity in Primary Cerebellar Granule Neurons. J. Food Lipids 2008, 15, 519–533. [Google Scholar] [CrossRef]
  210. Al-Naggar, T.; Gomez-Serranillos, M.; Carretero, M.; Villar, A. Neuropharmacological Activity of Nigella sativa L. Extracts. J. Ethnopharmacol. 2003, 88, 63–68. [Google Scholar] [CrossRef]
  211. El-Naggar, T.; Gómez-Serranillos, M.P.; Palomino, O.M.; Arce, C.; Carretero, M.E. Nigella sativa L. Seed Extract Modulates the Neurotransmitter Amino Acids Release in Cultured Neurons in Vitro. J. Biomed. Biotechnol. 2010, 2010, 398312. [Google Scholar] [CrossRef]
  212. Islam, M.H.; Ahmad, I.Z.; Salman, M.T. Neuroprotective Effects of Nigella sativa Extracts during Germination on Central Nervous System. Pharmacogn. Mag. 2015, 11, S182–S189. [Google Scholar] [CrossRef]
  213. Sabzghabaee, A.M.; Dianatkhah, M.; Sarrafzadegan, N.; Asgary, S.; Ghannadi, A. Clinical Evaluation of Nigella sativa Seeds for the Treatment of Hyperlipidemia: A Randomized, Placebo Controlled Clinical Trial. Med. Arch. 2012, 66, 198–200. [Google Scholar] [CrossRef]
  214. Al-Naqeep, G.; Al-Zubairi, A.S.; Ismail, M.; Amom, Z.H.; Esa, N.M. Antiatherogenic Potential of Nigella sativa Seeds and Oil in Diet-Induced Hypercholesterolemia in Rabbits. Evid.-Based Complement. Altern. Med. 2011, 2011, 213628. [Google Scholar] [CrossRef]
  215. Nader, M.A.; El-Agamy, D.S.; Suddek, G.M. Protective Effects of Propolis and Thymoquinone on Development of Atherosclerosis in Cholesterol-Fed Rabbits. Arch. Pharmacal Res. 2010, 33, 637–643. [Google Scholar] [CrossRef]
  216. Zaoui, A.; Cherrah, Y.; Alaoui, K.; Mahassine, N.; Amarouch, H.; Hassar, M. Effects of Nigella sativa Fixed Oil on Blood Homeostasis in Rat. J. Ethnopharmacol. 2002, 79, 23–26. [Google Scholar] [CrossRef]
  217. Bhatti, I.U.; Rehman, F.U.; Khan, M.A.; Marwat, S.K. Effect of Prophetic Medicine Kalonji (Nigella sativa L.) on Lipid Profile of Human Beings: An in Vivo Approach. World Appl. Sci. J. 2009, 6, 1053–1057. [Google Scholar]
  218. Randhawa, M.A.; Alghamdi, M.S. Anticancer Activity of Nigella sativa (Black Seed)—A Review. Am. J. Chin. Med. 2011, 39, 1075–1091. [Google Scholar] [CrossRef]
  219. Swamy, S.M.K.; Tan, B.K.H. Cytotoxic and Immunopotentiating Effects of Ethanolic Extract of Nigella sativa L. Seeds. J. Ethnopharmacol. 2000, 70, 1–7. [Google Scholar] [CrossRef]
  220. Kumara, S.S.M.; Huat, B.T.K. Extraction, Isolation and Characterisation of Antitumor Principle, α-Hederin, from the Seeds of Nigella sativa. Planta Medica 2001, 67, 29–32. [Google Scholar] [CrossRef]
  221. Al-Sheddi, E.S.; Farshori, N.N.; Al-Oqail, M.M.; Musarrat, J.; Al-Khedhairy, A.A.; Siddiqui, M.A. Cytotoxicity of Nigella sativa Seed Oil and Extract against Human Lung Cancer Cell Line. Asian Pac. J. Cancer Prev. 2014, 15, 983–987. [Google Scholar] [CrossRef]
  222. Farah, I.O.; Begum, R.A. Effect of Nigella sativa (N. sativa L.) and Oxidative Stress on the Survival Pattern of MCF-7 Breast Cancer Cells. Biomed. Sci. Instrum. 2003, 39, 359–364. [Google Scholar]
  223. Salim, E.I.; Fukushima, S. Chemopreventive Potential of Volatile Oil From Black Cumin (Nigella sativa L.) Seeds Against Rat Colon Carcinogenesis. Nutr. Cancer 2003, 45, 195–202. [Google Scholar] [CrossRef]
  224. Shaheen, N.; Azam, A.; Ganguly, A.; Anwar, S.; Parvez, M.S.A.; Punyamurtula, U.; Hasan, M.K. Anti-Inflammatory and Analgesic Activities of Black Cumin (BC, Nigella sativa L.) Extracts in in Vivo Model Systems. Bull. Natl. Res. Cent. 2022, 46, 26. [Google Scholar] [CrossRef]
  225. Alrashidi, M.; Derawi, D.; Salimon, J.; Yusoff, M.F. The Effects of Different Extraction Solvents on the Yield and Antioxidant Properties of Nigella sativa Oil from Saudi Arabia. J. Taibah Univ. Sci. 2022, 16, 330–336. [Google Scholar] [CrossRef]
  226. Lorina Badger, E.; Promise Madu, E.; Tahir Mehmood, K. Antimicrobial Activity of Nigella sativa L. Seed Oil against Multi-Drug Resistant Staphylococcus Aureus Isolated from Diabetic Wounds. Pak. J. Pharm. Sci. 2015, 28, 1985–1990. [Google Scholar]
  227. Hanafy, M.S.M.; Hatem, M.E. Studies on the Antimicrobial Activity of Nigella sativa Seed (Black Cumin). J. Ethnopharmacol. 1991, 34, 275–278. [Google Scholar] [CrossRef]
  228. Abo-Neima, S.E.; El-Sheekh, M.M.; Al-Zaban, M.I.; EL-Sayed, A.I.M. Antibacterial and Anti-Corona Virus (229E) Activity of Nigella sativa Oil Combined with Photodynamic Therapy Based on Methylene Blue in Wound Infection: In Vitro and in Vivo Study. BMC Microbiol. 2023, 23, 274. [Google Scholar] [CrossRef]
  229. Khan, A.; Chen, H.-C.; Tania, M.; Zhang, D.-Z. Anticancer Activities of Nigella sativa (Black Cumin). Afr. J. Tradit. Complement. Altern. Med. 2011, 8. [Google Scholar] [CrossRef]
  230. Niu, Y.; Wang, B.; Zhou, L.; Ma, C.; Waterhouse, G.I.N.; Liu, Z.; Ahmed, A.F.; Sun-Waterhouse, D.; Kang, W. Nigella sativa: A Dietary Supplement as an Immune-Modulator on the Basis of Bioactive Components. Front. Nutr. 2021, 8, 722813. [Google Scholar] [CrossRef]
  231. Wei, J.; Wang, B.; Chen, Y.; Wang, Q.; Ahmed, A.F.; Zhang, Y.; Kang, W. The Immunomodulatory Effects of Active Ingredients From Nigella sativa in RAW264.7 Cells Through NF-κB/MAPK Signaling Pathways. Front. Nutr. 2022, 9, 899797. [Google Scholar] [CrossRef]
  232. Majdalawieh, A.F.; Fayyad, M.W. Immunomodulatory and Anti-Inflammatory Action of Nigella sativa and Thymoquinone: A Comprehensive Review. Int. Immunopharmacol. 2015, 28, 295–304. [Google Scholar] [CrossRef]
  233. Boskabady, M.-H.; Keyhanmanesh, R.; Khameneh, S.; Doostdar, Y.; Khakzad, M.-R. Potential Immunomodulation Effect of the Extract of Nigella sativa on Ovalbumin Sensitized Guinea Pigs. J. Zhejiang Univ. Sci. B 2011, 12, 201–209. [Google Scholar] [CrossRef]
  234. Ebru, U.; Burak, U.; Yusuf, S.; Reyhan, B.; Arif, K.; Faruk, T.H.; Emin, M.; Aydın, K.; Lhan Atilla, İ.; Semsettin, S.; et al. Cardioprotective Effects of Nigella sativa Oil on Cyclosporine A-Induced Cardiotoxicity in Rats. Basic Clin. Pharmacol. Toxicol. 2008, 103, 574–580. [Google Scholar] [CrossRef]
  235. Hassan, M.Q.; Akhtar, M.; Ahmed, S.; Ahmad, A.; Najmi, A.K. Nigella sativa Protects against Isoproterenol-Induced Myocardial Infarction by Alleviating Oxidative Stress, Biochemical Alterations and Histological Damage. Asian Pac. J. Trop. Biomed. 2017, 7, 294–299. [Google Scholar] [CrossRef]
  236. Hamdan, A.; Haji Idrus, R.; Mokhtar, M.H. Effects of Nigella sativa on Type-2 Diabetes Mellitus: A Systematic Review. Int. J. Environ. Res. Public Health 2019, 16, 4911. [Google Scholar] [CrossRef]
  237. Maideen, N.M.P. Antidiabetic Activity of Nigella sativa (Black Seeds) and Its Active Constituent (Thymoquinone): A Review of Human and Experimental Animal Studies. Chonnam Med. J. 2021, 57, 169–175. [Google Scholar] [CrossRef]
  238. Mathur, M.L.; Gaur, J.; Sharma, R.; Haldiya, K.R. Antidiabetic Properties of a Spice Plant Nigella sativa. J. Endocrinol. Metab. 2011, 1, 1–8. [Google Scholar] [CrossRef]
  239. Beheshti, F.; Khazaei, M.; Hosseini, M. Neuropharmacological Effects of Nigella sativa. Avicenna J. Phytomed. 2016, 6, 104–116. [Google Scholar]
  240. Seghatoleslam, M.; Alipour, F.; Shafieian, R.; Hassanzadeh, Z.; Edalatmanesh, M.A.; Sadeghnia, H.R.; Hosseini, M. The Effects of Nigella sativa on Neural Damage after Pentylenetetrazole Induced Seizures in Rats. J. Tradit. Complement. Med. 2016, 6, 262–268. [Google Scholar] [CrossRef]
  241. Saadat, S.; Aslani, M.R.; Ghorani, V.; Keyhanmanesh, R.; Boskabady, M.H. The Effects of Nigella sativa on Respiratory, Allergic and Immunologic Disorders, Evidence from Experimental and Clinical Studies, a Comprehensive and Updated Review. Phytother. Res. 2021, 35, 2968–2996. [Google Scholar] [CrossRef]
  242. Gholamnezhad, Z.; Shakeri, F.; Saadat, S.; Ghorani, V.; Boskabady, M.H. Clinical and Experimental Effects of Nigella sativa and Its Constituents on Respiratory and Allergic Disorders. Avicenna J. Phytomed. 2019, 9, 195–212. [Google Scholar]
  243. Jarmakiewicz-Czaja, S.; Zielińska, M.; Helma, K.; Sokal, A.; Filip, R. Effect of Nigella sativa on Selected Gastrointestinal Diseases. Curr. Issues Mol. Biol. 2023, 45, 3016–3034. [Google Scholar] [CrossRef]
  244. Shakeri, F.; Gholamnezhad, Z.; Mégarbane, B.; Rezaee, R.; Boskabady, M.H. Gastrointestinal Effects of Nigella sativa and Its Main Constituent, Thymoquinone: A Review. Avicenna J. Phytomed. 2016, 6, 9–20. [Google Scholar]
  245. Eid, A.M.; Elmarzugi, N.A.; Abu Ayyash, L.M.; Sawafta, M.N.; Daana, H.I. A Review on the Cosmeceutical and External Applications of Nigella sativa. J. Trop. Med. 2017, 2017, e7092514. [Google Scholar] [CrossRef]
  246. Nasiri, N.; Ilaghi Nezhad, M.; Sharififar, F.; Khazaneha, M.; Najafzadeh, M.J.; Mohamadi, N. The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid.-Based Complement. Altern. Med. 2022, 2022, e7993579. [Google Scholar] [CrossRef]
  247. Rafati, S.; Niakan, M.; Naseri, M. Anti-Microbial Effect of Nigella sativa Seed Extract against Staphylococcal Skin Infection. Med. J. Islam. Repub. Iran 2014, 28, 42. [Google Scholar]
  248. Abu-Zinadah, O. Using Nigella sativa Oil to Treat and Heal Chemical Induced Wound of Rabbit Skin. JKAU Sci. 2009, 21, 335–346. [Google Scholar] [CrossRef]
  249. Widyaswari, M.S.; Noventi, I.; Sufriyana, H. Anti-Eczema Mechanism of Action of Nigella sativa for Atopic Dermatitis: Computer-Aided Prediction and Pathway Analysis Based on Protein-Chemical Interaction Networks. Biomol. Health Sci. J. 2019, 2, 68–74. [Google Scholar] [CrossRef]
  250. Ahmed, J.H.; Ibraheem, A.Y.; Al-Hamdi, K.I. Evaluation of Efficacy, Safety and Antioxidant Effect of Nigella sativa in Patients with Psoriasis: A Randomized Clinical Trial. J. Clin. Exp. Investig. 2014, 5, 186–193. [Google Scholar] [CrossRef]
  251. Parhizkar, S.; Latiff, L.A.; Parsa, A. Effect of Nigella sativa on Reproductive System in Experimental Menopause Rat Model. Avicenna J. Phytomed. 2016, 6, 95–103. [Google Scholar]
  252. Latiff, L.A.; Parhizkar, S.; Dollah, M.A.; Hassan, S.T.S. Alternative Supplement for Enhancement of Reproductive Health and Metabolic Profile among Perimenopausal Women: A Novel Role of Nigella sativa. Iran. J. Basic Med. Sci. 2014, 17, 980–985. [Google Scholar]
  253. Cho Ping, N.; Hashim, N.H.; Hasan Adli, D.S. Effects of Nigella sativa (Habbatus Sauda) Oil and Nicotine Chronic Treatments on Sperm Parameters and Testis Histological Features of Rats. Evid.-Based Complement. Altern. Med. 2014, 2014, e218293. [Google Scholar] [CrossRef]
  254. Mohammad, M.; Mohamad, M.; Daradka, H. Effects of Black Seeds (Nigella sativa) on Spermatogenesis and fertility of male albino rats. Res. J. Med. Med. Sci. 2009, 4, 386–390. [Google Scholar]
  255. Boka, J.; Mahdavi, A.; Samie, A.; Jahanian, R. Effect of Different Levels of Black Cumin (Nigella sativa L.) on Performance, Intestinal Escherichia coli Colonization and Jejunal Morphology in Laying Hens. J. Anim. Physiol. Anim. Nutr. 2014, 98, 373–383. [Google Scholar] [CrossRef]
  256. Kapan, M.; Tekin, R.; Onder, A.; Firat, U.; Evliyaoglu, O.; Taskesen, F.; Arikanoglu, Z. Thymoquinone Ameliorates Bacterial Translocation and Inflammatory Response in Rats with Intestinal Obstruction. Int. J. Surg. 2012, 10, 484–488. [Google Scholar] [CrossRef]
  257. Salem, E.M.; Yar, T.; Bamosa, A.O.; Al-Quorain, A.; Yasawy, M.I.; Alsulaiman, R.M.; Randhawa, M.A. Comparative Study of Nigella sativa and Triple Therapy in Eradication of Helicobacter Pylori in Patients with Non-Ulcer Dyspepsia. Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc. 2010, 16, 207–214. [Google Scholar]
  258. Ali, T.; Hussain, F.; Naeem, M.; Khan, A.; Al-Harrasi, A. Nanotechnology Approach for Exploring the Enhanced Bioactivities and Biochemical Characterization of Freshly Prepared Nigella sativa L. Nanosuspensions and Their Phytochemical Profile. Front. Bioeng. Biotechnol. 2022, 10, 888177. [Google Scholar] [CrossRef]
Figure 1. Nigella sativa used in different traditional medical systems for the treatment of various diseases.
Figure 1. Nigella sativa used in different traditional medical systems for the treatment of various diseases.
Molecules 29 04914 g001
Figure 2. (a) Chemical structures of key bioactive compounds from Nigella sativa. (b) The graph illustrates the relative prevalence of thymoquinone, p-cymene, camphene, thymol, terpinol, and alpha-thujene, highlighting their significance among the wide range of bioactive constituents found in Nigella sativa. The compounds were quantified using different techniques, such as gas chromatography (GC) and mass spectrometry (MS), followed by different extraction methods, such as supercritical fluid and Soxhlet extraction.
Figure 2. (a) Chemical structures of key bioactive compounds from Nigella sativa. (b) The graph illustrates the relative prevalence of thymoquinone, p-cymene, camphene, thymol, terpinol, and alpha-thujene, highlighting their significance among the wide range of bioactive constituents found in Nigella sativa. The compounds were quantified using different techniques, such as gas chromatography (GC) and mass spectrometry (MS), followed by different extraction methods, such as supercritical fluid and Soxhlet extraction.
Molecules 29 04914 g002aMolecules 29 04914 g002b
Figure 3. Schematic illustration of the proposed immunomodulatory pathways of thymoquinone. Thymoquinone stimulates B and T lymphocyte activation, promotes antibody production, regulates the release of cytokines (TNF, IL-1, and IL-6), and increases the cytotoxicity of NK cells.
Figure 3. Schematic illustration of the proposed immunomodulatory pathways of thymoquinone. Thymoquinone stimulates B and T lymphocyte activation, promotes antibody production, regulates the release of cytokines (TNF, IL-1, and IL-6), and increases the cytotoxicity of NK cells.
Molecules 29 04914 g003
Figure 4. Nigella sativa exhibits protective effects against bacteria, fungi, parasites, and viruses through diverse and potent defense mechanisms.
Figure 4. Nigella sativa exhibits protective effects against bacteria, fungi, parasites, and viruses through diverse and potent defense mechanisms.
Molecules 29 04914 g004
Figure 5. The schematic illustration demonstrates how thymoquinone reduces nitric oxide (NO) and inflammatory mediators, potentially alleviating symptoms and decreasing the likelihood of additional health complications in tuberculosis (TB). Additionally, the image emphasizes targeting type 2 alveolar cells by mycobacterium tuberculosis (MTB), underscoring the promising potential of thymoquinone in combating this infectious respiratory disease.
Figure 5. The schematic illustration demonstrates how thymoquinone reduces nitric oxide (NO) and inflammatory mediators, potentially alleviating symptoms and decreasing the likelihood of additional health complications in tuberculosis (TB). Additionally, the image emphasizes targeting type 2 alveolar cells by mycobacterium tuberculosis (MTB), underscoring the promising potential of thymoquinone in combating this infectious respiratory disease.
Molecules 29 04914 g005
Table 1. Percentage yield of some solvent-extracted oils from N. sativa seeds of different countries [14].
Table 1. Percentage yield of some solvent-extracted oils from N. sativa seeds of different countries [14].
CountryYield %ReferenceCountryYield %Reference
Morocco37[15]Egypt34.8[16]
Italy13–23[17]Iran40[18]
Tunisia28
31.7
[19]Turkey32
30–36
[20]
Pakistan31.2[21]Bangladesh 32[22]
Yemen36.8–38.4[23]Saudi Arabia38.2[24]
Table 2. Key bioactive substances in Nigella Sativa and their importance: a comprehensive summary.
Table 2. Key bioactive substances in Nigella Sativa and their importance: a comprehensive summary.
Compound TypeBioactive CompoundsActivity Against
Microorganism
Mode of ActionReference
Quinones
ThymoquinoneStaphylococcus aureus (ATCC 9144)Inhibition of bacterial cell wall synthesis[122]
DithymoquinoneSARS-CoV-19Inhibition of viral replication[123]
Terpenes and Terpenoids
Alpha-hederinEV71 subgenotypes C3 and C4aInhibition of viral replication[124]
CarvacrolCandida albicansDisruption of fungal cell membranes[125]
ThymolMoldsDisruption of fungal cell membranes[126]
P-cymeneSalmonella typhi (ATCC 14028)Inhibition of bacterial growth[127]
CampheneCandida albicansDisruption of fungal cell membranes[128]
Alkaloids
NigellidineEscherichia coli (ATCC 25922)Inhibition of bacterial enzymes[129]
NigellimineCOVID-19Inhibition of viral entry[80]
Nigellimine-N-oxideNANANA
MelanthinToxicNANA
NigellidineCOVID-19Inhibition of viral replication[82]
NigellucinNANANA
Fatty Acids
and Sterols
Linoleic AcidAlternaria solani, Candida albicans, Crinipellis pernicosa, Fusarium oxysporum, Pyrenophora avanae, Pythium ultimum, and Rhizoctonia solaniDisruption of fungal cell membranes[130]
Palmitic AcidAspergillus flavusDisruption of fungal cell membranes[131]
Beta-sitosterolHuman Immunodeficiency VirusInhibition of viral entry[132]
Myristic AcidNANANA
Arachidonic AcidStaphylococcus aureusLipid Peroxidation[133]
Oleic AcidCandida glabrataDisruption of fungal cell membranes[134]
Gamma-linolenic AcidHIVDestroys HIV-infected cells[135]
Phenolic Compound
EugenolTrichophyton rubrumDisruption of fungal cell membranes[136]
Tocols
Alpha-Tocopherol-Scavenging free radicals[137]
Gamma-Tocopherol-Inhibition of pro-inflammatory mediators[138]
Table 3. Toxicity profiles of bioactive compounds in Nigella sativa.
Table 3. Toxicity profiles of bioactive compounds in Nigella sativa.
Sr. No.Compound NamePubChem CIDMolWeight (g/mol)MutagenicTumorigenicIrritant
1Nigellidine136828302294.3N 1NN
2Nigellimine20725203.24NNN
3Pentyl hexadec-12-enoate74340768324.5Y 2NY
4Pentyl (Z)-pentadec-11-enoate171120962310.5YNY
5Lauric Acid3893200.32YYY
6Myristic Acid11005228.37YNY
7Palmitic Acid985256.42NYY
8Vanillic acid8468168.15YNN
9Epicatechin72276290.27NNN
10Quercetin5280343302.23YYN
11Apigenin5280443270.24YNN
123-Hydroxybenzoic acid7420138.12NNN
13Flavone10680222.24YNN
14Myricetin5281672318.23YNN
16Naringenin439246272.25YNN
17Kaempferol5280863286.24YNN
18Chrysin5281607254.24NNN
19Pinocembrin68071256.25NNN
20Galangin5281616270.24YNN
21Camphene6616136.23YNN
22Linalool6549154.25YNY
23Camphor2537152.23YYY
24Nerol643820154.25NNN
25Carvone7439150.22YYY
26Thymoquinone10281164.2YNN
27Umbellulone442504150.22NNN
28Carvacrol10364150.22NNY
29Longifolene289151204.35NNN
30Cyclosativene519960204.35NNN
31Aromadendrene91354204.35NYY
32Myrcene31253136.23NYY
33p-CYMENE7463134.22NYY
34Limonene22311136.23YYY
35Terpinolene11463136.23NNN
36Citronellyl acetate9017198.3NNY
37Thymohydroquinone95779166.22YYN
38Tricyclene79035136.23NNN
39Borneol1201518154.25YNY
40Myrtenol10582152.23NNY
41Cuminaldehyde326148.2NNY
42Bornyl acetate6448196.29NNY
43Thymol6989150.22YNN
44Methyl geranate5365910182.26YNY
45Neryl acetate1549025196.29YYY
46Sabinene18818136.23NNN
47Estragole8815148.2YYY
48Myristicin4276192.21NNY
49Apiole10659222.24YNN
50Eugenol3314164.2NNN
51Dodecanal8194184.32YNY
52Benzaldehyde240106.12YYY
53Coumarin323146.14YYN
54Tetradecanal31291212.37YNY
55Methyl linoleate5284421294.5NNN
1 No, 2 Yes.
Table 4. Drug-likeness and pharmacokinetic properties of bioactive compounds in Nigella sativa.
Table 4. Drug-likeness and pharmacokinetic properties of bioactive compounds in Nigella sativa.
Sr. No.Compound NamecLogPSolubilityTPSADrug-LikenessDrug Score
1Nigellidine1.54−2.2943.81.510.83
2Nigellimine2.11−2.8331.4−0.420.64
3Pentyl hexadec-12-enoate8.01−5.2526.3−27.080.09
4Pentyl (Z)-pentadec-11-enoate7.55−4.9826.3−27.060.08
5Lauric Acid4.24−3.1637.3−25.220.08
6Myristic Acid5.15−3.737.3−25.220.12
7Palmitic Acid6.06−4.2437.3−25.010.09
8Vanillic acid0.73−1.3566.8−1.310.35
9Epicatechin1.51−1.761101.920.87
10Quercetin1.49−2.491271.60.3
11Apigenin2.34−2.86871.210.47
123-Hydroxybenzoic acid0.8−1.3357.5−4.270.3
13Flavone3.37−3.7426.31.850.45
14Myricetin1.14−2.21470.750.46
16Naringenin2.16−2.64871.90.51
17Kaempferol1.84−2.791070.90.46
18Chrysin2.68−3.1566.80.970.75
19Pinocembrin2.5−2.9466.81.950.83
20Galangin2.18−3.08870.660.44
21Camphene2.8−2.690−5.860.27
22Linalool3.23−2.1520.2−6.680.16
23Camphor2.18−2.4517.1−3.710.06
24Nerol3.49−1.8920.2−3.570.45
25Carvone2.65−2.1917.1−18.990.1
26Thymoquinone1.64−1.6834.1−1.20.35
27Umbellulone2.07−2.1717.1−2.810.5
28Carvacrol2.84−2.5320.2−2.590.29
29Longifolene4.06−3.810−7.760.37
30Cyclosativene3.71−3.770−6.860.39
31Aromadendrene4−3.790−7.140.14
32Myrcene4.29−2.50−7.820.09
33p-CYMENE3.19−2.830−5.630.21
34Limonene3.36−2.541.7−21.850.06
35Terpinolene3.45−2.341.9−3.020.46
36Citronellyl acetate3.83−2.5626.3−4.290.25
37Thymohydroquinone2.5−2.2440.5−6.330.22
38Tricyclene2.45−2.670−2.380.5
39Borneol2.04−2.420.2−3.530.17
40Myrtenol1.79−2.0120.2−1.560.33
41Cuminaldehyde2.78−2.8117.1−11.10.27
42Bornyl acetate2.52−2.8126.3−3.690.28
43Thymol2.84−2.5320.2−3.020.17
44Methyl geranate3.56−226.3−10.380.21
45Neryl acetate3.97−2.326.3−2.880.1
46Sabinene2.86−2.690−6.780.45
47Estragole2.62−2.359.23−3.750.1
48Myristicin2.73−3.0627.7−2.290.17
49Apiole2.66−3.0836.9−4.670.27
50Eugenol2.27−2.0529.5−2.780.11
51Dodecanal4.38−3.3917.1−22.310.08
52Benzaldehyde1.59−1.9417.1−4.050.11
53Coumarin1.5−2.3726.3−1.830.12
54Tetradecanal5.29−3.9317.1−22.30.07
55Methyl linoleate6.89−4.4526.3−35.730.22
Table 5. An overview of the pharmacological applications of Nigella sativa.
Table 5. An overview of the pharmacological applications of Nigella sativa.
Pharmacological ApplicationFormulationMechanism of ActionPotential Side EffectsClinical EvidenceReferences
Anti-inflammatory EffectsNigella sativa oil or extractInhibition of inflammatory pathways, such as NF-κB, by active component thymoquinone.Limited reports of gastrointestinal discomfort.Some studies support anti-inflammatory effects in various conditions.[141,143,198,224]
Antioxidant PropertiesNigella sativa seed extract or oilPresence of antioxidants (e.g., thymoquinone) to neutralize free radicals and reduce oxidative stress.Generally well tolerated; rare reports of allergic reactions.Evidence supports antioxidant properties in vitro and in animal studies.[79,141,143,225]
Antimicrobial ActivityNigella sativa seed oilThymoquinone exhibits antimicrobial properties, disrupting cell membranes and inhibiting protein synthesis.Limited reports of skin irritation; caution in pregnant women.Limited clinical evidence; more research is needed for specific infections. [147,226,227,228]
Anticancer PotentialNigella sativa oil or thymoquinoneInduction of apoptosis, inhibition of cell proliferation, and anti-inflammatory effects.Limited studies; potential interactions with cancer treatments.Some promising preclinical evidence; more research is needed in humans. [75,229]
Immunomodulatory EffectsNigella sativa extractModulation of the immune system, enhancing activity of immune cells (e.g., T cells and natural killer cells), and regulating cytokine production.Rare reports of allergic reactions; caution in autoimmune diseases.Limited clinical evidence; potential benefits observed in some studies. [175,230,231,232,233]
Cardioprotective EffectsNigella sativa oil or extractReduction of oxidative stress, inflammation, and improvement of lipid profiles.Generally well tolerated; caution in individuals with bleeding disorders.Positive effects on cardiovascular risk factors were observed in some studies. [44,234,235]
Antidiabetic EffectsNigella sativa seed powder or oilPotential hypoglycemic effects, improving insulin sensitivity and reducing complications associated with diabetes.Caution in hypoglycemic individuals: monitor blood sugar levels.Some studies suggest improved glycemic control; more research is needed. [76,231,236,237,238]
Neuroprotective PropertiesNigella sativa oil or extractNeuroprotective effects by reducing oxidative stress, inflammation, and apoptosis in certain neurological conditions.Generally well tolerated; caution in individuals with neurological disorders.Positive effects observed in preclinical models; limited human studies.[79,212,232,239,240]
Respiratory HealthNigella sativa essential oilPotential bronchodilator effects, easing symptoms of asthma and improving respiratory function.Limited reports of throat irritation; avoid in excessive amounts.Limited clinical evidence; more research is needed for respiratory conditions.[232,241,242]
Gastrointestinal HealthNigella sativa seed powderGastroprotective effects promote the healing of gastric ulcers and reduce gastrointestinal disorder symptoms.Rare reports of nausea and bloating; consult with a healthcare professional.Some evidence for gastroprotective effects in animal studies.[238,243,244]
Skin HealthNigella sativa oil or creamAnti-inflammatory and antioxidant properties may benefit skin conditions, such as eczema and psoriasis.Patch test recommended; rare reports of skin irritation.There is limited clinical evidence; more research is needed for specific skin conditions.[245,246,247,248,249,250]
Reproductive HealthNigella sativa supplementationPotential fertility benefits in both men and women, may regulate menstrual cycles and improve sperm parameters.Consultation with a healthcare provider is advised, especially during pregnancy.Limited clinical evidence; more research is needed for fertility outcomes.[251,252,253,254]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Abbas, M.; Gururani, M.A.; Ali, A.; Bajwa, S.; Hassan, R.; Batool, S.W.; Imam, M.; Wei, D. Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. Molecules 2024, 29, 4914. https://doi.org/10.3390/molecules29204914

AMA Style

Abbas M, Gururani MA, Ali A, Bajwa S, Hassan R, Batool SW, Imam M, Wei D. Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. Molecules. 2024; 29(20):4914. https://doi.org/10.3390/molecules29204914

Chicago/Turabian Style

Abbas, Munawar, Mayank Anand Gururani, Amjad Ali, Sakeena Bajwa, Rafia Hassan, Syeda Wajiha Batool, Mahreen Imam, and Dongqing Wei. 2024. "Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review" Molecules 29, no. 20: 4914. https://doi.org/10.3390/molecules29204914

APA Style

Abbas, M., Gururani, M. A., Ali, A., Bajwa, S., Hassan, R., Batool, S. W., Imam, M., & Wei, D. (2024). Antimicrobial Properties and Therapeutic Potential of Bioactive Compounds in Nigella sativa: A Review. Molecules, 29(20), 4914. https://doi.org/10.3390/molecules29204914

Article Metrics

Back to TopTop